Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Cervical Cancer, December 2025

Free Subscription


Abstracts

Retrieve all available abstracts of the following 373 articles:
HTML format


 

Single Articles

  1. WANG J, Chen A, Chen Q, Niu H, et al
    Classifying the tumor immune microenvironment in cervical cancer based on nuclear cytoplasmic consistent genes.
    Sci Rep. 2025;15:42703.
    PubMed    
    Abstract available

  2. HAYASHI T, Abiko K, Konishi I
    CHARACTERISTIC OF MYELOID SARCOMA BY CANCER GENOME PROFILING AND ALGORITHM OF POTENTIAL BIOMARKERS FOR UTERINE MESENCHYMAL TUMOR.
    Georgian Med News. 2025;:6-13.
    PubMed    
    Abstract available

  3. CHANG X, Qu X, Ren T, Wu T, et al
    Decoding Triphenotypic Neutrophils in Cervical Cancer Evolution and Targeting SPP1+/GBP1+/ELOVL5+ Tumor-Associated Neutrophils to Sensitize Immunotherapy.
    Adv Sci (Weinh). 2025 Nov 28:e15511. doi: 10.1002/advs.202515511.
    PubMed    
    Abstract available

  4. AHMED AA
    Dual Repurposing Strategy: Rivaroxaban and Ciprofloxacin as a Synergistic Anticancer Therapy in Cervical Cancer: Insight into Inhibition of Metastasis via Targeting the EMT Pathway.
    Asian Pac J Cancer Prev. 2025;26:4195-4207.
    PubMed    
    Abstract available

  5. ABDULL RAHIM U, Mohd Yusof YA, Mustapa M, Nurdin A, et al
    Synergistic Chemopreventive Effects of Curcumin, Gingerol, and Shogaol on HeLa Cervical Cancer Cells.
    Asian Pac J Cancer Prev. 2025;26:4087-4096.
    PubMed    
    Abstract available

  6. JUNTAMONGKOL T, Siranart N, Phutinart S, Chitwarodom C, et al
    Disparities in Human Papillomavirus Vaccination and Cervical Cancer Prevention and Screening Strategies: A Meta-Analysis.
    Asian Pac J Cancer Prev. 2025;26:3997-4008.
    PubMed    
    Abstract available

  7. GOUDIRA NC, Sherzai F, Petersen LK
    Cytology and high-risk human papillomavirus testing to reduce colposcopies in women with postcoital bleeding.
    Dan Med J. 2025;72:A12240920.
    PubMed    
    Abstract available

  8. HAN Y, Chen H, Song D, Li R, et al
    Evolving landscape of female cancers along with attributable risk factors in China from 1990 to 2021, and projections to 2040.
    Front Public Health. 2025;13:1629081.
    PubMed    
    Abstract available

  9. SIBARANI CNR, Suardi D, Salima S, Nathania N, et al
    Beyond the Pelvis: Brain Metastases in Cervical Cancer - A Case Series from a Low-Middle-Income Country.
    Int J Womens Health. 2025;17:4745-4753.
    PubMed    
    Abstract available

  10. CHEN C, Hu Z, Xu Q, Yuan L, et al
    Development and validation of machine learning models for assessing the risk of postoperative venous thromboembolism in cervical cancer patients.
    Sci Rep. 2025 Nov 27. doi: 10.1038/s41598-025-29761.
    PubMed    
    Abstract available

  11. TU H, Liu G, Gu H, Liu Z, et al
    Impact of treatment modality on survival in FIGO stage IIB cervical cancer: a population-based propensity-score matched analysis.
    Sci Rep. 2025;15:42280.
    PubMed    
    Abstract available

  12. THAPA S, Davies JC, Crosbie EJ, Payne K, et al
    Understanding preferences for self-sampling in a national cervical screening programme: a protocol for a discrete choice experiment.
    BMJ Open. 2025;15:e101800.
    PubMed    
    Abstract available

  13. PIETA E, Panek A, Szczepanek-Dulska M, Pogoda K, et al
    Vimentin-targeting adaptogen withaferin A: Potential to selectively suppress cervical cancer - Single-cell microspectroscopic and molecular analysis.
    Biochim Biophys Acta Mol Basis Dis. 2025 Nov 25:168125.
    PubMed    
    Abstract available

  14. FRIDSTEN S, Hellman K, Sundin A, Nedar L, et al
    Timing of MRI for early treatment response prediction of chemoradiotherapy in uterine cervical cancer.
    Eur J Radiol. 2025;195:112566.
    PubMed    
    Abstract available

  15. GAO H, Qu H, Sun S, Zong L, et al
    Cervical Cancer Metastasis Presenting as Small Bowel Stricture.
    Dig Dis Sci. 2025 Nov 27. doi: 10.1007/s10620-025-09586.
    PubMed    


  16. YANG Y, Cheng S, Zhong Y, Sun P, et al
    Exploring tumor heterogeneity and drug resistance in cervical cancer through single-cell and bulk transcriptomics.
    Discov Oncol. 2025 Nov 27. doi: 10.1007/s12672-025-04037.
    PubMed    
    Abstract available

  17. CHI Y, Dong P, Zhang N, Liu B, et al
    TGM2 Regulates Radiosensitivity via POGZ-Mediated Repair of DNA Double-Strand Breaks in Cervical Cancer.
    Cancer Sci. 2025 Nov 27. doi: 10.1111/cas.70277.
    PubMed    
    Abstract available

  18. GURBUZ T, Serindag C, Onal ZE, Balik R, et al
    HPV Vaccine Recommendation Among Pediatricians: A KAP Study of Knowledge and Beliefs in Clinical Practice.
    Niger J Clin Pract. 2025;28:1130-1138.
    PubMed    
    Abstract available

  19. GUO A, Su Z, Zhang E, Lin H, et al
    Multi-omics reveals that NOTCH1 promotes cervical cancer progression and reduces radiosensitivity.
    Front Immunol. 2025;16:1703032.
    PubMed    
    Abstract available

  20. SUN T, Zhao R, Zhang Y, Li D, et al
    Astragalus polysaccharides combined with radiochemotherapy for cervical cancer: a systematic review and meta-analysis of randomized controlled studies.
    Front Pharmacol. 2025;16:1699902.
    PubMed    
    Abstract available

  21. SHI L, Chen H, Zhang Z, Wang Y, et al
    Evolving HPV diagnostics: current practice and future frontiers.
    Front Cell Infect Microbiol. 2025;15:1681779.
    PubMed    
    Abstract available

  22. ZHAO H, Guo Y, Wang L, Li R, et al
    A novel disulfidptosis-related lncRNA signature to predict prognosis and immune response of cervical cancer.
    Medicine (Baltimore). 2025;104:e46023.
    PubMed    
    Abstract available

  23. JIN P, Gu C, Huang S, Liu X, et al
    Clinical pathological analysis of primary small cell neuroendocrine carcinoma of the cervix: A retrospective study.
    Medicine (Baltimore). 2025;104:e46168.
    PubMed    
    Abstract available

  24. WANG Z, Yang L, Li C, Jiang P, et al
    A bidirectional Mendelian randomization analysis of the causal relationship between immune cells and high-grade squamous intraepithelial lesion.
    Medicine (Baltimore). 2025;104:e45695.
    PubMed    
    Abstract available

  25. YANG X, Fu J, Xu Y, Li D, et al
    Photothermal Therapy Combined with Chemotherapy and Anti-Inflammation Therapy Weakens the Immunosuppression of Cervical Cancer.
    Pharmaceuticals (Basel). 2025;18:1657.
    PubMed    
    Abstract available

  26. PETRICA LA, Deacu M, Cozaru GC, Mitroi AF, et al
    Interplay Between Immune Microenvironment CD8(+) Tumor-Infiltrating Lymphocytes and PDL-1 Expression as Prognostic Markers in Invasive Cervical Squamous Cell Carcinoma.
    Medicina (Kaunas). 2025;61:2007.
    PubMed    
    Abstract available

  27. RUIZ-HERNANDEZ J, Anda-Jauregui G, Hernandez-Lemus E
    Drug Repositioning for HPV Clade-Specific Cervicouterine Cancer Using the OCTAD Pipeline.
    Int J Mol Sci. 2025;26:11238.
    PubMed    
    Abstract available

  28. RIMSKAYA E, Gorevoy A, Devyatkina A, Nazarova N, et al
    Raman Spectroscopy of Cell-Free Cervicovaginal Lavage for HPV Lesion Diagnosis: A Pilot Study.
    Int J Mol Sci. 2025;26:11064.
    PubMed    
    Abstract available

  29. GUZMAN-VENEGAS M, Moreno-Leon C, Andrade-Madrigal C, Roman A, et al
    Prevalence of Torque Teno Virus (TTV) in Cervical Precursor Lesions and Cancer in Chilean Women.
    Int J Mol Sci. 2025;26:11039.
    PubMed    
    Abstract available

  30. NYALAMBISA A, Alabi BA, Dlamini Z, Marima R, et al
    Elucidating Circular Ribonucleic Acid Mechanisms Associated with Splicing Factor 3 Inhibition in Cervical Cancer.
    Int J Mol Sci. 2025;26:10883.
    PubMed    
    Abstract available

  31. LEE YJ, Kim SY, Lee NK, Lee SW, et al
    Changes in Smoking Patterns and Cervical Cancer Risk: Preventive Implications from a Nationwide Japanese Cohort.
    Healthcare (Basel). 2025;13:2852.
    PubMed    
    Abstract available

  32. PETOUSIS S, Almperis A, Margioula-Siarkou C, Guyon F, et al
    Adjuvant Treatment for Surgically-Treated Cervical Cancer Patients: A Comprehensive Review.
    Cancers (Basel). 2025;17:3710.
    PubMed    
    Abstract available

  33. GARCIA-BARRIENTOS NT, Solorzano-Ibarra F, Klimov-Kravtchenko K, Rojas-Diaz JM, et al
    T Cell Exhaustion in the Cervical Cancer Tumor Microenvironment: PD-1 Overexpression and Co-Expression with TIGIT, Tim-3, LAG-3, and NKG2A.
    Cancers (Basel). 2025;17:3627.
    PubMed    
    Abstract available

  34. BOEMI S, Pavan M, Siena R, Lo Giudice C, et al
    Locally Advanced Cervical Cancer: Multiparametric MRI in Gynecologic Oncology and Precision Medicine.
    Diagnostics (Basel). 2025;15:2858.
    PubMed    
    Abstract available

  35. SENTHILKUMAR G, Pitchaimuthu R, Panneerselvam PS, Alagarswamy RP, et al
    Integrative Long Non-Coding RNA Analysis and Recurrence Prediction in Cervical Cancer Using a Recurrent Neural Network.
    Diagnostics (Basel). 2025;15:2848.
    PubMed    
    Abstract available

  36. CHEN YH, Wu JX, Yang SF, Chen TH, et al
    Cepharanthine Induces Oxidative Stress and Apoptosis in Cervical Cancer via the Nrf2/Keap1 Pathway.
    Antioxidants (Basel). 2025;14:1324.
    PubMed    
    Abstract available

  37. ASARE M, Obiri-Yeboah D, Ken-Amoah S, Akakpo PK, et al
    HPV self-sampling for cervical cancer screening among women living with HIV in Ghana: protocol for a hybrid type 1 effectiveness-implementation randomized controlled trial.
    Trials. 2025;26:550.
    PubMed    
    Abstract available

  38. VIEIRA YP, Cesar Zoppellaro Reis R, de Araujo Versola H, Rodrigues da Cunha Fontoura M, et al
    Prevalence of mammography and cytopathological exams before and during the COVID-19 pandemic.
    BMC Womens Health. 2025;25:580.
    PubMed    
    Abstract available

  39. NDAPATANI L, Kubo E, Munene A, Odhiambo C, et al
    Cervical cancer screening and treatment of VIA positive lesions among women living with HIV in Nairobi and Kajiado counties, Kenya: results from a targeted intervention implemented under the USAID Fahari ya Jamii project in supported HIV clinics.
    BMC Womens Health. 2025 Nov 26. doi: 10.1186/s12905-025-04185.
    PubMed    
    Abstract available

  40. CHENG N, Li X, Jin Z, Liu Y, et al
    Cervical cancer screening uptake questionnaire (CCSTQ) for women: instrument development and validation.
    BMC Womens Health. 2025;25:577.
    PubMed    
    Abstract available

  41. ABATE A, Azage M
    High risk HPV among HIV positive women with normal and abnormal cervical cytology in Bahir Dar, north west Ethiopia.
    Sci Rep. 2025;15:42198.
    PubMed    
    Abstract available

  42. PAKDAMAN K, Alizadeh-Nodehi A, Lashkarbolouki AH, Esmaeilnia Shirvani A, et al
    Brain Metastases in Cervical Cancer: A Global Systematic Review and Meta-Analysis of Incidence and Clinicopathological Features.
    Cancer Rep (Hoboken). 2025;8:e70405.
    PubMed    
    Abstract available

  43. LIU W, Zhang L, Wang Y, Jiang X, et al
    Astragalus polysaccharide hinders cervical cancer immune escape by targeting NR3C2 and activating SLC40A1.
    Biochim Biophys Acta Mol Basis Dis. 2025 Nov 24:168123.
    PubMed    
    Abstract available

  44. XU Q, Deng Z, Liu J, Zhuo Y, et al
    Molecular and immune correlates of response to first-line de-escalated chemotherapy plus penpulimab and anlotinib in advanced cervical cancer.
    Cancer Discov. 2025 Nov 26. doi: 10.1158/2159-8290.CD-25-1315.
    PubMed    
    Abstract available

  45. KO K, Fukuda M, Yamanoi K, Hayashi N, et al
    Real-world multicenter study of immune checkpoint inhibitors in advanced cervical cancer across HPV-associated and HPV-independent subtypes.
    Int J Clin Oncol. 2025 Nov 26. doi: 10.1007/s10147-025-02924.
    PubMed    
    Abstract available

  46. IRENE PARELLADA C, Siddiqui AH, Oliver E, Hughes R, et al
    Sex disparities of vaccine-preventable cancer mortality in Latin America.
    J Med Econ. 2025;28:2071-2081.
    PubMed    
    Abstract available

  47. CALVO A, Hall S, Melgar Cossich VB, Andreadakis J, et al
    HPV Vaccine Uptake and Cervical Cancer Trends in Panama: A Reference Point for Future Impact Studies.
    Vaccines (Basel). 2025;13:1173.
    PubMed    
    Abstract available

  48. DANISCH M, Postl M, Bartl T, Grimm C, et al
    Novel Treatment Concepts for Cervical Cancer-Moving Towards Personalized Therapy.
    J Pers Med. 2025;15:523.
    PubMed    
    Abstract available

  49. IBIS K, Durmaz M, Yanik D, Bunul I, et al
    Machine Learning-Based Prognostic Modelling Using MRI Radiomic Data in Cervical Cancer Treated with Definitive Chemoradiotherapy and Brachytherapy.
    Curr Oncol. 2025;32:602.
    PubMed    
    Abstract available

  50. MARTIN E, Reina G, Carlos S
    Advances in Therapeutic Vaccines Against HPV: A Review of Human Clinical Trials.
    Curr Oncol. 2025;32:600.
    PubMed    
    Abstract available

  51. SALVADOR S
    HPV Testing, Self-Collection, and Vaccination: A Comprehensive Approach to Cervical Cancer Prevention.
    Curr Oncol. 2025;32:594.
    PubMed    
    Abstract available

  52. FELISI NM, Oyet D, Yung KMM, Ochola E, et al
    Barriers and Facilitators to Cervical Cancer Screening in Northern Uganda: Qualitative Insights from Healthcare Workers and Administrators.
    Curr Oncol. 2025;32:591.
    PubMed    
    Abstract available

  53. WANG X, Chen Y, Huang J, He Q, et al
    Comparative Efficacy of Photodynamic Therapy and Cold Knife Conization for Cervical High-Grade Squamous Intraepithelial Lesions.
    Curr Oncol. 2025;32:590.
    PubMed    
    Abstract available

  54. XIE H, Huang J, Ye M, Xu J, et al
    Integrated HPV Testing, TCT, and Colposcopic VIA/VILI Improves Detection Rate for HSIL and Cervical Cancer: A Retrospective Cohort in China.
    Int J Womens Health. 2025;17:4649-4660.
    PubMed    
    Abstract available

  55. OTSUBO M, Aichi M, Kawashima Y, Yamanaka S, et al
    Malignant peritoneal mesothelioma as a secondary cancer following radiotherapy for cervical cancer: a case report and literature review.
    Gynecol Oncol Rep. 2025;62:101979.
    PubMed    
    Abstract available

  56. ALI B
    Evaluation of the Frequency and Patterns of Cervical Cancer Recurrence After Treatment Using ;18F-FDG PET-CT: A Cross-Sectional Study.
    Health Sci Rep. 2025;8:e71566.
    PubMed    
    Abstract available

  57. BOUCHHIMA N, Ammar M, Ksentini M, Zghal K, et al
    Impact of an Educational Intervention Video in HPV Prevention among Tunisian Female Students: A before-and-after Study.
    J Prev Med Hyg. 2025;66:E279-E290.
    PubMed    
    Abstract available

  58. XIONG L, Wen B, Tan D
    Analysis of the first inpatient expenditure for cervical cancer patients before and during the COVID-19 pandemic in a provincial maternal and children care hospital in China.
    BMC Res Notes. 2025;18:495.
    PubMed    
    Abstract available

  59. NUERTEY BD, Ansong J, Nartey EB, Gyimah L, et al
    Screening for cervical cancer among adult women: a self-reported nationwide study in Ghana.
    BMC Womens Health. 2025 Nov 25. doi: 10.1186/s12905-025-04180.
    PubMed    


  60. MOON TD, Salcedo MP, Mavume-Mangunyane E, Sidat M, et al
    A hybrid type III effectiveness-implementation study designed to test implementation best practices of deploying a Screen-Triage-Treat approach to cervical cancer screening and management utilizing self-collected HPV DNA testing in Chokwe District, Mo
    BMC Public Health. 2025 Nov 25. doi: 10.1186/s12889-025-25730.
    PubMed    
    Abstract available

  61. ZHUANG S, Deng X, Fu F, Zhang Z, et al
    Mapping cellular interactions and communication landscapes in cervical cancer via single-cell transcriptomics.
    Discov Oncol. 2025 Nov 25. doi: 10.1007/s12672-025-04040.
    PubMed    
    Abstract available

  62. TRAN VT, Pham TH, Phan NKC
    Cervical image visualization and improvement for clinical support in diagnosis and treatment.
    Sci Rep. 2025;15:41732.
    PubMed    
    Abstract available

  63. WISE J
    HPV vaccine safe and reduces risk of cervical cancer, anti-misinformation review finds.
    BMJ. 2025;391:r2479.
    PubMed    


  64. SAINI V, Barman S, Pradhan S, Shinghal A, et al
    Automating IMRT planning for cervical cancer using dimension-scaled prior-based Vanilla Bayesian optimization.
    Phys Med Biol. 2025 Nov 25. doi: 10.1088/1361-6560/ae2419.
    PubMed    
    Abstract available

  65. MOSE D, Katana G, Chea SK, Ayieko P, et al
    Uptake and factors associated with cervical cancer screening among women aged 18-49 years at a public hospital in Coastal Kenya.
    PLOS Glob Public Health. 2025;5:e0004907.
    PubMed    
    Abstract available

  66. DOGHMAN I, Montero-Macias R, Malassigne V, Puech J, et al
    HPV Genomic Status in Early Cervical Cancer and Its Prognosis Association.
    J Med Virol. 2025;97:e70720.
    PubMed    
    Abstract available

  67. HU J, Qi Z, Hu S, Xu X, et al
    Endoplasmic Reticulum Stress-Driven LncRNA Signature Predicts Cervical Cancer Prognosis and Guides Personalized Immunotherapy: A Multi-Omics and Functional Validation Study.
    Carcinogenesis. 2025 Nov 25:bgaf087. doi: 10.1093.
    PubMed    
    Abstract available

  68. PARK KT, Park JW, Jeon YJ, Bak JK, et al
    Risk of Pelvic Insufficiency Fractures in Cervical Cancer Survivors: Using the National Claim Database.
    J Korean Med Sci. 2025;40:e292.
    PubMed    
    Abstract available

  69. PAVONE M, Innocenzi C, Macellari N, Cantarini C, et al
    Assessing the Accuracy of Large Language Models on European Guidelines for Cervical Cancer: An In Silico Benchmarking Study.
    BJOG. 2025 Nov 24. doi: 10.1111/1471-0528.70095.
    PubMed    
    Abstract available

  70. ZAMANI N, Kolaei RB, Nemati F, Jouybari AD, et al
    Dose-dependent effects of wheat germ oil and vitamin E on apoptosis and gene expression in breast and cervical cancer cell lines with single-cell RNA-seq profiling.
    Sci Rep. 2025;15:41569.
    PubMed    
    Abstract available

  71. GU X, Zhang T, Yao H, Guo F, et al
    CRISPR-Cas12a-integrated pregnancy test strip biosensors: Visual detection of telomerase and miRNA let-7a in cervical cancer diagnostics.
    Biosens Bioelectron. 2025 Nov 24:118241. doi: 10.1016/j.bios.2025.118241.
    PubMed    
    Abstract available

  72. WIERENGA F, Dievert H, Chiang B, Yang H, et al
    Uptake and feasibility of HPV self-sampling among patients of a Canadian family medicine clinic.
    Can Fam Physician. 2025;71.
    PubMed    
    Abstract available

  73. GEREND MA, Wilkinson LJ, Pendleton C, Sutin AR, et al
    Weight discrimination and up-to-date breast and cervical cancer screening in US women.
    Prev Med. 2025;202:108470.
    PubMed    
    Abstract available

  74. LIU L, Zhuang S, Zheng J, Lin F, et al
    Treatment Patterns and Prognosis of Cervical Cancer Patients Aged 65 and Older: A Population-Based Cohort Study.
    Ann Surg Oncol. 2025 Nov 24. doi: 10.1245/s10434-025-18687.
    PubMed    
    Abstract available

  75. SABANAYAGAM R, Krishnamoorthy S, Balasubramanian V, Muthusami S, et al
    EGF induces SOD activity, TNF-alpha/IL-6 expression and complement regulatory proteins in cervical cancer cells: suppression by EGCG.
    Med Oncol. 2025;43:15.
    PubMed    
    Abstract available

  76. POSCHEL B, Neis KJ
    [Cervical cancer screening in Germany 2020-2022 : An analysis of the first round of screening according to the specifications of the oKFE-RL].
    Pathologie (Heidelb). 2025 Nov 24. doi: 10.1007/s00292-025-01500.
    PubMed    
    Abstract available

  77. ZOU H, Xiong W, He Y
    Single-cell and spatial transcriptome-based metabolism-immunity interaction network and therapeutic target discovery of matrine in cervical cancer.
    Naunyn Schmiedebergs Arch Pharmacol. 2025.
    PubMed    
    Abstract available

  78. ALI N, Sykes Martin KD, Tobillo R, Meiyappan K, et al
    Risk factors and clinical outcomes of radiation-induced fistula after chemoradiation and image-guided brachytherapy for locally advanced cervical cancer.
    Gynecol Oncol Rep. 2025;62:101977.
    PubMed    
    Abstract available

  79. MAGHIMAA M
    Exploring the mechanisms of action of polyphenols in the treatment of cervical cancer.
    3 Biotech. 2025;15:430.
    PubMed    
    Abstract available

  80. HILLER GGR, Wolf B, Forberger M, Freude A, et al
    Trop2 expression, p16 expression status, and histologic subtype in carcinoma of the uterine cervix.
    Pathol Oncol Res. 2025;31:1612252.
    PubMed    
    Abstract available

  81. JIA C, Li N, Lu T, Shen X, et al
    Construction and validation of the prediction model for fear of cancer recurrence in patients with postoperative cervical cancer.
    Front Oncol. 2025;15:1670680.
    PubMed    
    Abstract available

  82. TUSAR MTT, Haq N, Gazi HR, Farazi R, et al
    Designing a Multi-Epitope Vaccine Against HPV 16, 18, 33, and 45 Targeting L1 and E7 Proteins: An Immunoinformatics Approach for Cervical Cancer Prevention and Therapy.
    Bioinform Biol Insights. 2025;19:11779322251391076.
    PubMed    
    Abstract available

  83. SOLBJOR M, Hagen M, Harstad I, Baasland I, et al
    Reflections about attendance in the Norwegian cervical cancer screening program among the youngest invited women aged 25-29 years: a qualitative interview study.
    Scand J Public Health. 2025 Nov 24:14034948251393105.
    PubMed    
    Abstract available

  84. FENG J, Shang Z, Ge B, Chu K, et al
    Analysis of the effect of dual reference lines on first positioning accuracy in intensity-modulated radiotherapy for cervical cancers.
    J Appl Clin Med Phys. 2025;26:e70342.
    PubMed    
    Abstract available

  85. LEE HS, Hong GU, Jeong W, Oh K, et al
    Information Landscape on Cervical Cancer: An Analysis of News and Online Platform Data in the Republic of Korea.
    Health Commun. 2025 Nov 24:1-19. doi: 10.1080/10410236.2025.2587893.
    PubMed    
    Abstract available

  86. HENSCHKE N, Bergman H, Buckley BS, Crosbie EJ, et al
    Effects of human papillomavirus (HPV) vaccination programmes on community rates of HPV-related disease and harms from vaccination.
    Cochrane Database Syst Rev. 2025;11:CD015363.
    PubMed    
    Abstract available

  87. BERGMAN H, Henschke N, Arevalo-Rodriguez I, Buckley BS, et al
    Human papillomavirus (HPV) vaccination for the prevention of cervical cancer and other HPV-related diseases: a network meta-analysis.
    Cochrane Database Syst Rev. 2025;11:CD015364.
    PubMed    
    Abstract available

  88. LIBERACKA-DWOJAK M, Wilkosc-Debczynska M, Makarewicz R
    The role of perceived stress in the relationship between sexual communication, health literacy, and quality of life in women diagnosed with cervical cancer.
    Patient Educ Couns. 2025;143:109428.
    PubMed    
    Abstract available

  89. COSTA JM, Pimentel AL, Duarte I, Moreira AC, et al
    Barriers to cervical cancer screening: a cross-sectional study of non-adherent Portuguese women.
    BMC Prim Care. 2025 Nov 22. doi: 10.1186/s12875-025-03121.
    PubMed    
    Abstract available

  90. BILGE C, Kaydirak M, Gurel SN, Yurtsever D, et al
    Relationship Between HPV Vaccine Hesitancy and Attitudes Towards Early Detection of Cervical Cancer in Women of Reproductive Age.
    Enferm Clin (Engl Ed). 2025 Nov 20:502363. doi: 10.1016/j.enfcle.2025.502363.
    PubMed    
    Abstract available

  91. TONG Y, Deng W, Xu L, Li Y, et al
    A prognostic model derived from PANoptosis-associated subtypes unveils immunological features and therapeutic vulnerabilities in cervical cancer.
    Discov Oncol. 2025 Nov 22. doi: 10.1007/s12672-025-04115.
    PubMed    
    Abstract available

  92. GHOSH S, Bhatnagar P, Chabbra R
    Effect of educational intervention on knowledge of HPV and HPV vaccine and vaccine acceptability among teachers: A pilot investigation.
    Indian J Cancer. 2025;62:402-407.
    PubMed    
    Abstract available

  93. ASLAN E, Kaya Senol D, Akin Eroglu S, Turkmenoglu A, et al
    The impact of brachytherapy on sexual life in patients with gynecological cancer.
    Eur J Oncol Nurs. 2025;79:103012.
    PubMed    
    Abstract available

  94. BRUERA S, Huang Y, Bowman S, Suarez-Almazor ME, et al
    Human papillomavirus vaccine uptake in ethnically diverse women living with systemic lupus erythematosus.
    Lupus. 2025;34:1437-1444.
    PubMed    
    Abstract available

  95. SANLI C, Dogan Yuksekol O, Ulucan M, Baltaci N, et al
    Stigmatization and social isolation experienced by Human Papillomavirus-positive women: A phenomenological study.
    Women Health. 2025;65:749-760.
    PubMed    
    Abstract available

  96. BRYNDA D, Nemejcova K, Cibula D, Slama J, et al
    The role of HPV testing in the follow-up of patients in different clinical scenarios after diagnosis of cervical preinvasive lesions and carcinomas.
    Expert Rev Anticancer Ther. 2025;25:1405-1413.
    PubMed    
    Abstract available

  97. NARAYANAN PP S, Murugan A, Ramakrishnan J, Rajan Parasuraman Udayakumar K, et al
    Parental perspectives: a mixed method study on perceived risk, self-efficacy, vaccine response efficacy, and willingness for adolescent HPV vaccination in Puducherry, South India.
    Int J Adolesc Med Health. 2025;37:359-369.
    PubMed    
    Abstract available

  98. SILVA ADL, Marelli JGA, Lira Lopes MW, Rodrigues MT, et al
    Epstein-barr virus (EBV) in cervical carcinoma detected by in situ hybridization targeting ebers and the viral genome.
    Braz J Microbiol. 2025;56:2733-2742.
    PubMed    
    Abstract available

  99. DAVIES JC, Carter S, Cao J, Whittaker M, et al
    Urine human papillomavirus testing for cervical screening in a UK general screening population: a diagnostic test accuracy study.
    Br J Gen Pract. 2025;75:e853-e861.
    PubMed    
    Abstract available

  100. ACUNA MJ, Mancilla E, Acuna D, Bernal G, et al
    Prevalence of Human Papillomavirus in Arica and Antofagasta, in the north of Chile.
    Cancer Epidemiol. 2025;99:102913.
    PubMed    
    Abstract available

  101. WANG Z, Yao P, Shen S, Shao P, et al
    DMCA-Net: Dual-branch multi-granularity hierarchical contrast and cross-attention network for cervical abnormal cell detection.
    Neural Netw. 2025;192:107890.
    PubMed    
    Abstract available

  102. LIAO B, Chen L, Ruan J, Wang R, et al
    Microbiome and gartynecologic cancer.
    Cancer Lett. 2026;636:217940.
    PubMed    
    Abstract available

  103. LAI YK, Ye JF, Newcombe K, Zhao X, et al
    Empowering Unvaccinated Women with Information: How Online Cancer Information Seeking and Scanning Encourage HPV Vaccination in China.
    Health Commun. 2025;40:2985-2997.
    PubMed    
    Abstract available


  104. Screening for cervical cancer.
    CA Cancer J Clin. 2026;76:e70049.
    PubMed    


  105. PERKINS RB, Wolf AMD, Church TR, Elkin EB, et al
    Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline.
    CA Cancer J Clin. 2026;76:e70041.
    PubMed    
    Abstract available

  106. RAMIREZ LVH, Forero HE, Grosso MPN, Rincon EHH, et al
    Advances in artificial intelligence for the early detection of cervical cancer in adult women: a scoping review.
    Rev Bras Ginecol Obstet. 2025;47:e-rbgo76.
    PubMed    
    Abstract available

  107. ZHANG M, Hong X, Ma N, Wei Z, et al
    Correction: the promoting effect and mechanism of Nrf2 on cell metastasis in cervical cancer.
    J Transl Med. 2025;23:1373.
    PubMed    


  108. SALHI I, Alzahayqa M, Qrei W, Qawasmi T, et al
    Genotypic spectrum and prevalence of HPV associated with cervical cancer in Palestine.
    BMC Infect Dis. 2025 Dec 3. doi: 10.1186/s12879-025-12276.
    PubMed    


  109. CHEN C, Zhang F, Shen J, Zheng Q, et al
    CLC3 regulates V-ATPase to enhance lysosomal degradation and cisplatin resistance in cervical cancer cells.
    Cell Death Discov. 2025 Dec 3. doi: 10.1038/s41420-025-02876.
    PubMed    
    Abstract available

  110. ACHILONU O, Ayeni O, Adeleke M, Mmereki D, et al
    Treatment patterns, care delays and outcomes in advanced cervical cancer: study protocol for a mixed retrospective and prospective single-centre cohort in South Africa.
    BMJ Open. 2025;15:e105299.
    PubMed    
    Abstract available

  111. CHEN Y, Zhong L, Chen J, Li X, et al
    Glutamine modified lipid nanoparticles loaded with GPX4 siRNA for cervical cancer targeting.
    Int J Biol Macromol. 2025 Dec 1:149419. doi: 10.1016/j.ijbiomac.2025.149419.
    PubMed    
    Abstract available

  112. WANG J, Hu Y, Gong J, Chen L, et al
    Nicotine Activates PI3K/AKT Pathway to Induce Cellular Proliferation, Invasion, and Migration in HPV-16 Positive Cervical Cancer SiHa Cells.
    J Appl Toxicol. 2025 Dec 3. doi: 10.1002/jat.70019.
    PubMed    
    Abstract available

  113. LAL M, K G, Nair SN, Pal UM, et al
    Design of a Flexible Silicon-based Speculum for Cervical Imaging.
    Annu Int Conf IEEE Eng Med Biol Soc. 2025;2025:1-4.
    PubMed    
    Abstract available

  114. GONG N, Takeyama S, Yamaguchi M, Urata T, et al
    Robust Papanicolaou Stain Quantification Insensitive to Imaging System Variations by Sparsity-based Stain Unmixing().
    Annu Int Conf IEEE Eng Med Biol Soc. 2025;2025:1-7.
    PubMed    
    Abstract available

  115. PARK S, Lim H, Gumel AB
    Mathematical Assessment of the Roles of Vaccination and Pap Screening on the Burden of HPV and Related Cancers in Korea.
    Bull Math Biol. 2025;87:182.
    PubMed    
    Abstract available

  116. DEMIRKAYA DB, Arslan HS, Azarkan SY
    Investigation of cytotoxic, molecular and in silico effects of chlorambucil and tamoxifen on 2D/3D MDA-MB-231 and HeLa cancer cell models.
    Mol Biol Rep. 2025;53:159.
    PubMed    
    Abstract available

  117. ARUM A, Andreasen EK, Pedersen H, Nielsen TD, et al
    Large-Scale Study Comparing Analytical and Diagnostic Quality of Three HPV Self-Sampling Devices for At-Home Cervical Cancer Screening.
    APMIS. 2025;133:e70109.
    PubMed    
    Abstract available

  118. HUANG Y, He M, Li L, Xie R, et al
    The vaccination status and attitudes toward human papillomavirus among gynecologists in China: A cross-sectional survey.
    Hum Vaccin Immunother. 2025;21:2578902.
    PubMed    
    Abstract available

  119. ZHU Y, Xiang D, Xing H, Li Y, et al
    Nutritional and inflammatory markers for predicting delirium after radical hysterectomy for cervical cancer: development of a nomogram.
    Front Nutr. 2025;12:1644157.
    PubMed    
    Abstract available

  120. CORN E, Becht K, Adefres B, Monare B, et al
    Assessing the Clinical Utility of MRI for Preoperative Staging of Early-Stage Cervical Cancer in a Limited-Resource Setting: A Retrospective Cohort Study from Botswana.
    Res Sq [Preprint]. 2025 Nov 18:rs.3.rs-8041378. doi: 10.21203/rs.3.rs-8041378.
    PubMed    
    Abstract available

  121. HAWKES D, Saville M, Starkie R, Hassan S, et al
    Accuracy of self-collection in human papillomavirus-based cervical screening: An evidence-based review.
    Aust J Gen Pract. 2025;54:881-886.
    PubMed    
    Abstract available

  122. TROJNARSKA D, Wielgus M, Gornisiewicz K, Kot J, et al
    Challenges and opportunities in managing pregnant patients with abnormal cervical cytology and positive HPV result in Poland: a single-center retrospective analysis.
    Folia Med Cracov. 2025;65:101-111.
    PubMed    
    Abstract available

  123. ONGKO EG, Budiana ING, Winata IGS, Mahendra INB, et al
    High expression of vascular endothelial growth factor is a risk factor for poor response to neoadjuvant Paclitaxel - carboplatin chemotherapy in stage IB3, IIA2, and IIB cervical cancer.
    Med J Malaysia. 2025;80:787-792.
    PubMed    
    Abstract available

  124. YANG J, Liu Q, Tang Y, Huang K, et al
    Retrospective analysis of cervical screening abnormalities in women with type 3 transformation zone without visible lesions.
    PeerJ. 2025;13:e20396.
    PubMed    
    Abstract available

  125. XU Q, He C, Zhu X, Xia Y, et al
    Deep Learning and Attention Mechanism-based Prediction of Vaginal Invasion in Early-Stage Cervical Cancer.
    Curr Med Imaging. 2025 Nov 28. doi: 10.2174/0115734056392471251103125700.
    PubMed    
    Abstract available

  126. LIU X, Liu X, Li Y, Bai S, et al
    Predictive framework for cervical cancer brachytherapy fractionation mode integrating generative model and dynamic feature aggregation GNNs.
    BMC Med Inform Decis Mak. 2025 Dec 1. doi: 10.1186/s12911-025-03294.
    PubMed    


  127. SUN Y, Chen Y, Zeng Z, Zhou B, et al
    Metal artifact reduction in spectral computed tomography for intracavity brachytherapy in cervical cancer patients: a prospective study.
    Radiat Oncol. 2025 Dec 1. doi: 10.1186/s13014-025-02767.
    PubMed    


  128. CHAUHAN R, Dagar G, Malhotra L, Gupta A, et al
    Targeting ubiquitin-specific protease 14 reduces metastatic potential and metabolic activity in cervical cancer via direct modulation of monocarboxylate transporter-4.
    J Transl Med. 2025 Dec 2. doi: 10.1186/s12967-025-07442.
    PubMed    
    Abstract available

  129. HINKEL RE, Kalima M, Msadabwe SC, Mwaba CK, et al
    False-Positive Screening, Over-Referral, and Length of time between Cervical Cancer Early Detection and Confirmed Diagnosis Over Nine Years in Lusaka, Zambia.
    J Epidemiol Glob Health. 2025 Dec 1. doi: 10.1007/s44197-025-00478.
    PubMed    
    Abstract available

  130. LUGAN E, Lacorre A, Margueritte F, Ouldamer L, et al
    Locally advanced cervical cancer and para-aortic lymphadenectomy: impact of the number of removed lymph nodes, a FRANCOGYN group study.
    Eur J Surg Oncol. 2025;51:110490.
    PubMed    
    Abstract available

  131. CHOI S, Karabukayeva A, Davlyatov G, Opoku-Agyeman W, et al
    Association Between Regional Competition and Cancer Screening Rates at Federally Qualified Health Centers.
    J Ambul Care Manage. 2026;49:E40-E48.
    PubMed    
    Abstract available

  132. DONG S, Feng YN, Li XY, Du XS, et al
    Preoperative non-invasive prediction of lymph node metastasis in cervical cancer using a multiparametric radiomics model based on transvaginal ultrasound.
    Abdom Radiol (NY). 2025 Dec 1. doi: 10.1007/s00261-025-05297.
    PubMed    
    Abstract available

  133. BADINER N, Guthrie L, Stevenson E, Folkerts A, et al
    Exploratory study of a long-term hospital-based cervical cancer screening program in a high HIV prevalence area of rural Malawi.
    Gynecol Oncol Rep. 2025;62:101986.
    PubMed    
    Abstract available

  134. XIAO C, Deng J, Ren F, Zhang C, et al
    Cervical cancer burden among females under 40?years in China, Japan, and South Korea, 1990-2021: a systematic analysis for the global burden of disease study 2021.
    Front Public Health. 2025;13:1695004.
    PubMed    
    Abstract available

  135. WANG J, Bao S, Huang T, Cai Y, et al
    Fusion model combining ultrasound-based radiomics and deep transfer learning with clinical parameters for preoperative prediction of pelvic lymph node metastasis in cervical cancer.
    Front Oncol. 2025;15:1681029.
    PubMed    
    Abstract available

  136. AMAAMRI-SEEBACH T, Mobarki M, Musawi S, Peoc'h M, et al
    SATB2 is Rarely Expressed in Endometrial or Endocervical Carcinoma.
    APMIS. 2025;133:e70110.
    PubMed    
    Abstract available

  137. PASCA NM, Taut D, Greenley R, Kirkegaard P, et al
    Exploring Emotional and Cognitive Perceptions of Cervical Cancer Screening and Self-Sampling Among Vulnerable Romanian Women: A Qualitative Study.
    Health Expect. 2025;28:e70485.
    PubMed    
    Abstract available

  138. LIN Z, Zhou Y, Liu Z, Nie W, et al
    Correction: Deciphering the tumor immune microenvironment: single-cell and spatial transcriptomic insights into cervical cancer fibroblasts.
    J Exp Clin Cancer Res. 2025;44:315.
    PubMed    


  139. NAYAB M, Elnaggar M, Asher V, Bali A, et al
    Comparative Analysis of FDG-PET Versus CT/MRI in Staging and Management of Advanced-stage Cervical Cancer.
    Anticancer Res. 2025;45:5503-5511.
    PubMed    
    Abstract available

  140. DAO THL, Nakamura K, Okamoto K, Vu TH, et al
    Leucine-rich Repeat-containing 15 as a Potential Marker and Therapeutic Target in Cervical Cancer.
    Anticancer Res. 2025;45:5409-5421.
    PubMed    
    Abstract available

  141. PAWAR M, Pingale S, Kadam K, Jadhav A, et al
    Artificial intelligence-driven screening, early diagnosis, and treatment strategies for cervical cancer: an overview.
    Infect Agent Cancer. 2025 Nov 28. doi: 10.1186/s13027-025-00716.
    PubMed    


  142. KALULU P, Olusanya OA, Salako A, Obodoechina N, et al
    Participatory implementation science to enhance knowledge and build the capacity to increase the uptake and sustainability of HPV vaccination among girls in Nigeria.
    J Health Popul Nutr. 2025;44:416.
    PubMed    
    Abstract available

  143. KUMAR P, Bateson D, Costa T, Ahmed S, et al
    HPV vaccination coverage and determinants in adolescent girls with disability: a scoping review.
    Vaccine. 2025;68:127968.
    PubMed    
    Abstract available

  144. ANDOH J, Taghavi K, Moono M, Basu P, et al
    Cervical intraepithelial neoplasia progression and regression among women living with HIV in Zambia.
    HIV Med. 2025 Nov 5. doi: 10.1111/hiv.70134.
    PubMed    
    Abstract available

  145. AVILA E, Mendez-Perez EA, Diaz L, Garcia-Quiroz J, et al
    Vasculogenic mimicry in human cancers associated with chronic high-risk human papillomavirus infection.
    Future Oncol. 2025;21:3677-3689.
    PubMed    
    Abstract available

  146. GAUTAM P, Zhao J, Levi C, Raman S, et al
    Potential Protective Effect of Statins against High-Grade Squamous Intraepithelial Lesions in Women with Metabolic Comorbidities.
    Cancer Epidemiol Biomarkers Prev. 2025;34:2169-2177.
    PubMed    
    Abstract available

  147. DESIEGHARDT A, Ding L, Ermel A, Franco EL, et al
    Population-Level Effectiveness and Herd Protection 17 Years After HPV Vaccine Introduction.
    JAMA Pediatr. 2025;179:1326-1334.
    PubMed    
    Abstract available

  148. RATTANAPITOON NK, Padchasuwan NH, La N, Rattanapitoon SK, et al
    Beyond virtual learning: Leveraging project ECHO to sustain and localize national cancer control plan implementation in LMICs.
    J Cancer Policy. 2025;46:100638.
    PubMed    
    Abstract available

  149. CHU H, Liu S
    Generating targeted and tailored health communication narratives with AI.
    Risk Anal. 2025;45:3505-3518.
    PubMed    
    Abstract available

  150. PANG L, He P, Han Y, Cui H, et al
    Semantic Consistency Network with Edge Learner and Connectivity Enhancer for Cervical Tumor Segmentation from Histopathology Images.
    Interdiscip Sci. 2025;17:917-934.
    PubMed    
    Abstract available

  151. YUILL S, Smith MA, Velentzis LS, Nisha M, et al
    Participation in the National Cervical Screening Program Among Women Who Gave Birth in New South Wales, Australia by Place of Maternal Birth: A Data Linkage Analysis.
    Aust N Z J Obstet Gynaecol. 2025;65:518-529.
    PubMed    
    Abstract available

  152. KHUNTSARIA I, Gachechiladze K, Lipartia E, Kobulashvili T, et al
    HPV vaccination and cervical cancer control in Georgia: evidence and projections.
    BMC Public Health. 2025 Dec 13. doi: 10.1186/s12889-025-25958.
    PubMed    


  153. LEE Y, Park SY, Shim BS, Kim B, et al
    miR-193a-5p-mediated Inhibition of the METTL1/COX-2 axis is critical for Astragalin-induced apoptosis in cervical cancer.
    Sci Rep. 2025 Dec 13. doi: 10.1038/s41598-025-32320.
    PubMed    
    Abstract available

  154. LI Y, Zheng K, Xu Q, Xie L, et al
    Global, regional, and national epidemiology of cervical cancer in elderly women from 1990 to 2021 and its prediction to 2035.
    BMC Public Health. 2025 Dec 13. doi: 10.1186/s12889-025-25029.
    PubMed    


  155. HUA Y, Xu Y, Wan J, Fan Y, et al
    A dual-responsive AI-designed peptide P9-conjugate disrupts E6-E6AP Interface to restore p53 and suppress HPV16-driven cervical cancer.
    J Control Release. 2025 Dec 11:114536. doi: 10.1016/j.jconrel.2025.114536.
    PubMed    
    Abstract available

  156. HOW JA, Jazaeri AA
    Photodynamic therapy: An alternative technique to cervical conization for cervical dysplasia.
    Med. 2025;6:100922.
    PubMed    
    Abstract available

  157. MOONO M, Sharma A, Bohlius J, Mwanahamuntu M, et al
    The Cervical Cancer Screening and Precancer Treatment Journey: A Qualitative Study of Experiences Among Zambian Women Living With and Without HIV.
    Oncologist. 2025 Dec 13:oyaf412. doi: 10.1093.
    PubMed    
    Abstract available

  158. LAI R, Sheng D, Geng Y, Ding C, et al
    (18)F-FDG PET based intratumoral and peritumoral explainable radiomics for predicting cervical cancer prognosis: A multi-center retrospective study.
    Hell J Nucl Med. 2025 Dec 15:s002449912907. doi: 10.1967/s002449912907.
    PubMed    
    Abstract available

  159. MAGONDU W, Ochola S, Rucha K
    Effects of Educational Intervention on Uptake of Cervical Cancer Preventive Services at Kenyatta University, Kenya; A Cluster Randomized Control Trial.
    J Cancer Educ. 2025 Dec 13. doi: 10.1007/s13187-025-02797.
    PubMed    
    Abstract available

  160. TAHIR M, Mohammed D, Sadiq C
    Prevalence and genotypic characterization of human papillomavirus in Iraqi women: a retrospective study of 2,193 cases.
    Virol J. 2025;22:394.
    PubMed    
    Abstract available

  161. FENG Y, Sun Z, Li Y, Wang F, et al
    A machine learning-based framework for prognostic prediction and tumor microenvironment characterization of locally advanced cervical cancer with concurrent chemoradiotherapy.
    NPJ Precis Oncol. 2025 Dec 12. doi: 10.1038/s41698-025-01234.
    PubMed    
    Abstract available

  162. LIU L, Han Z, Qian Q, Liu X, et al
    Unraveling the mechanisms of LncRNAs in cervical cancer: a comprehensive review.
    Cell Death Discov. 2025 Dec 13. doi: 10.1038/s41420-025-02902.
    PubMed    
    Abstract available

  163. HAMILTON G, Gamboa NA, Schlein AN, Ebrahimi S, et al
    Multi-Parameter Magnetic Resonance Spectroscopy in Cervix.
    NMR Biomed. 2026;39:e70211.
    PubMed    
    Abstract available

  164. BARRETT C, Joseph JT, Horning MP, Anne M, et al
    Performance of an artificial intelligence-based tool for cervical precancer screening in five countries in Africa: a prospective, observational, diagnostic accuracy study.
    Lancet Glob Health. 2026;14:e49-e60.
    PubMed    
    Abstract available

  165. PANT S
    Strides in Cervical Cancer Elimination.
    JAMA. 2025 Dec 12. doi: 10.1001/jama.2025.20021.
    PubMed    


  166. NI L, Li L, Li D, Ding Y, et al
    A dosimetric correlation between the bladder filling volume and its effects on radiation dose during high-dose-rate intracavitary brachytherapy in patients with cervical cancer.
    Discov Oncol. 2025 Dec 12. doi: 10.1007/s12672-025-04254.
    PubMed    
    Abstract available

  167. DEL PILAR BRICENO-CASADO M, Sanchez Vegas A, Alegre-Del-Rey EJ, Olry de Labry Lima A, et al
    Cost-effectiveness of second- or third-line treatment with tisotumab vedotin for metastatic or recurrent cervical cancer.
    Expert Rev Pharmacoecon Outcomes Res. 2025.
    PubMed    
    Abstract available

  168. LIU X, Wang W, Zhao Y, Gu X, et al
    SPP1, LYZ, and MCM5: potential diagnostic biomarkers for rheumatoid arthritis and cervical cancer comorbidity.
    Front Med (Lausanne). 2025;12:1693787.
    PubMed    
    Abstract available

  169. MCHUGH DJ, Datta A, Dubec MJ, Buckley DL, et al
    Intra-voxel incoherent motion biomarker repeatability in healthy volunteers and sensitivity to chemoradiotherapy-induced changes in patients with uterine cervical cancer.
    Front Oncol. 2025;15:1633456.
    PubMed    
    Abstract available

  170. DIJMARESCU AL, Camen IV, Manolea MM, Radu M, et al
    Delayed onset of HPV-associated uterine malignancies: seven pathogenetic factors in contrast to cervical cancer.
    Rom J Morphol Embryol. 2025;66:443-451.
    PubMed    
    Abstract available

  171. YUAN L, Jiang H, Xia M, Wen W, et al
    P4HA3 drives cervical cancer lymphatic metastasis by facilitating ACLY-mediated ferroptosis resistance.
    Cell Death Differ. 2025 Dec 11. doi: 10.1038/s41418-025-01644.
    PubMed    
    Abstract available

  172. HU L, Li J, Du Y, Mei F, et al
    Lobaplatin versus cisplatin in concurrent chemoradiotherapy for elderly cervical cancer: randomized controlled phase II study.
    J Gynecol Oncol. 2025 Nov 21. doi: 10.3802/jgo.2026.
    PubMed    
    Abstract available

  173. ZHAN Q, Xu N, Fan J, Wang J, et al
    Prognostic value of systemic immune-inflammation index in cervical cancer: a systematic review and meta-analysis.
    J Obstet Gynaecol. 2025;45:2601171.
    PubMed    
    Abstract available

  174. YANG Q, Zhang J, Shang X, Sun B, et al
    Fatty acid metabolism-related signature suggests an oncogenic role of FASN in cervical cancer.
    Transl Cancer Res. 2025;14:8032-8054.
    PubMed    
    Abstract available

  175. ANAND RAJ LFA, Shreya S, Rithika G, Namasivayam SKR, et al
    Multi-functional zinc oxide nanoparticles (ZnONps inspired from Myristica Fragrans seed extract against cervical Cancer, pyogenic bacteria and inflammatory response. a promising potential of ZnONps in cancer nanotherapy, infection control and inflamma
    3 Biotech. 2026;16:21.
    PubMed    
    Abstract available

  176. MABUCHI S, Komura N, Wakimoto Y, Ueda T, et al
    Salvage Radical Hysterectomy for Recurrent Cervical Cancer in a Previously Irradiated Field Using the hinotori Surgical Robot System: A Case Report.
    Cureus. 2025;17:e96395.
    PubMed    
    Abstract available

  177. LEVENTIC M, Matic J, Pavlovic Saftic D, Ban Z, et al
    Molecular Pathways Affected by Sulfonylpurine Derivatives in 2D and 3D HeLa Cell Models.
    Molecules. 2025;30:4659.
    PubMed    
    Abstract available

  178. NASERI P, Shahbazi-Gahrouei D, Rajaei-Nejad S
    Evaluation of Model Performance and Clinical Usefulness in Automated Rectal Segmentation in CT for Prostate and Cervical Cancer.
    Diagnostics (Basel). 2025;15:3090.
    PubMed    
    Abstract available

  179. PRETI M, Lewis F, Carcopino X, Bevilacqua F, et al
    Vulvar Inspection at the Time of Cervical Cancer Screening: European Society of Gynecological Oncology (ESGO), International Society for the Study of Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease (ECSVD), and European
    Obstet Gynecol Surv. 2025;80:759-761.
    PubMed    
    Abstract available

  180. NSAFUL J, Sefogah PE, Dedey F, Nartey E, et al
    Cervical cancer knowledge among high school students in Southern Ghana.
    BMC Womens Health. 2025 Dec 10. doi: 10.1186/s12905-025-04171.
    PubMed    
    Abstract available

  181. ZHANG Q, Tang H, Shen W, Gao J, et al
    LncRNA TYMSOS stimulates immune escape and the advancement of cervical squamous cell carcinoma by regulating miR-134-5p/KRAS expression.
    Inflamm Res. 2025;75:3.
    PubMed    
    Abstract available

  182. BAE S, Park JH, Oh S, Yang G, et al
    Public health impact and cost-effectiveness of implementing gender-neutral immunization with the nonavalent human papillomavirus vaccine in South Korea.
    Hum Vaccin Immunother. 2025;21:2582299.
    PubMed    
    Abstract available

  183. CHEN S, Zheng C
    POU6F1 inhibits cervical cancer progression by activating MAOB to block the ERK1/2 pathway.
    Tissue Cell. 2025;99:103257.
    PubMed    
    Abstract available

  184. ANDREA I NANEZ MD, Velez MA, Mae Zakhour Md, Garon EB, et al
    Differences in Clinical Trial Availability vs Distribution of Disease Among Gynecological Cancers.
    Oncology (Williston Park). 2025;39:456-462.
    PubMed    
    Abstract available

  185. SHIN MB, Axeen S, Cole AM, Guo XM, et al
    Nonadherence to Cervical Cancer Screening Guidelines in Commercially Insured US Adults, 2013-2021.
    JAMA Netw Open. 2025;8:e2548512.
    PubMed    


  186. ABUZOOR A, Jabin MSR, Eshareturi C, Nesbitt R, et al
    Using the Health Belief Model to Examine Parental Knowledge and Health Beliefs About Human Papilloma Virus (HPV) and iHPV Vaccine in Kuwait: Cross-Sectional Survey Study.
    JMIR Public Health Surveill. 2025;11:e75818.
    PubMed    
    Abstract available

  187. LIU M, Wang J, Luo L
    Self-Compassion Mediates the Relationship Between Social Support and Quality of Life in Cervical Cancer Patients: A Cross-Sectional Study.
    Cancer Manag Res. 2025;17:3039-3048.
    PubMed    
    Abstract available

  188. KLUTSE J, Tay YA, Attoh DA, Gyekye EF, et al
    Cervical Cancer in Women With HIV: A Call to Action for Equitable Prevention in Low- and Middle-Income Countries.
    Biomed Res Int. 2025;2025:1711050.
    PubMed    
    Abstract available

  189. BELDI MC, Colunna FC, Lorenzi NP, Lasso Larco JA, et al
    Uncoupling protein 2 and signal transducer and activator of transcription 1 are targets of human papillomavirus oncoproteins and may be prognostic markers for cervical cancer development.
    Front Oncol. 2025;15:1689058.
    PubMed    
    Abstract available

  190. QI Y, Chen X, Chi F, Chen Z, et al
    Dosimetric impact of bladder volume variation on online adaptive radiotherapy for cervical cancer based on cone-beam computed tomography and clinical management strategies.
    Quant Imaging Med Surg. 2025;15:12320-12335.
    PubMed    
    Abstract available

  191. NIE X, Wang L, Yang W, Maimaiti M, et al
    Study on the role and mechanism of magnesium-calcium-mineralized collagen composite scaffolds in the adjuvant treatment of cervical cancer.
    Regen Biomater. 2025;12:rbaf110.
    PubMed    
    Abstract available

  192. OLTHOF EMG, van den Brule AJC, Melchers WJG, Berkhof J, et al
    Improving Efficiency in Dutch Cervical Screening by Genotyping: An Analysis of Real World Program Data.
    J Med Virol. 2025;97:e70745.
    PubMed    
    Abstract available

  193. WANG H, Zhang J, Li J, Sun B, et al
    Expression of ACTR3 in cervical cancer and impact on immune cell infiltration and prognosis: A comprehensive analysis based on bulk RNA-Seq and single-cell RNA-Seq.
    Medicine (Baltimore). 2025;104:e46316.
    PubMed    
    Abstract available

  194. LUO X, Chen Y, He L, Liu S, et al
    HPV genotype distribution and cervical lesion severity in HPV-positive women: a study from the Guizhou Province cervical cancer screening program.
    Virol J. 2025 Dec 9. doi: 10.1186/s12985-025-03041.
    PubMed    
    Abstract available

  195. DE OLIVEIRA MC, Fortunato GM, da Silva PR, Pacheco BLB, et al
    CTLA4 genetic variants influence immune regulation and susceptibility of HPV associated cervical cancer.
    Discov Oncol. 2025 Dec 10. doi: 10.1007/s12672-025-04179.
    PubMed    
    Abstract available

  196. JAIN S, Jain A, Jangid M
    MGWO-CNN: hyperparameter optimization of CNN classifier for cervical cancer detection using Modified Grey Wolf Optimizer.
    Sci Rep. 2025;15:43514.
    PubMed    
    Abstract available


  197. Expression of concern "Remodeling of tumor microenvironment by cellular senescence and immunosenescence in cervical cancer" [Semin. Cancer Biol. 108 (2025) 17-32].
    Semin Cancer Biol. 2025;117:124.
    PubMed    


  198. CALDERON-MORA J, Molokwu J, Byrd TL, Alomari A, et al
    Program implementation and evaluation of De Casa en Casa: a tailored community-based cervical cancer screening program for underserved Hispanic women.
    Health Educ Res. 2025;40:cyaf055.
    PubMed    
    Abstract available

  199. LI Q, Cao Y, Yu Y, Zhang Y, et al
    Cervical/Anal HPV-Cytology Concordance With Colposcopic-Anoscopic Pathology: 984 Women Without HIV in China's Largest Lower Genital Tract Center.
    J Med Virol. 2025;97:e70710.
    PubMed    
    Abstract available

  200. ZHANG S, Wang F, Yang H, Wang L, et al
    Uterine manipulator-free minimally invasive surgery for early-stage cervical cancer: a step toward oncologic safety.
    Int J Surg. 2025 Dec 8. doi: 10.1097/JS9.0000000000004269.
    PubMed    


  201. OCAMPO-LOPEZ-ESCALERA J, Rosete-Aguilar M, Ochoa-Diaz-Lopez H, Sanchez-Chino XM, et al
    CPSMI2025: A curated dataset of conventional Pap smear microscopy images for deep learning-based cervical cancer screening.
    Data Brief. 2025;63:112272.
    PubMed    
    Abstract available

  202. HUA Y, Wang B, Su Q
    The relationship between posttreatment 18 F-fluorodeoxyglucose PET/computed tomography restaging and metabolic parameters with the prognosis of uterine cervical cancer.
    Nucl Med Commun. 2025 Dec 12. doi: 10.1097/MNM.0000000000002093.
    PubMed    
    Abstract available

  203. PAVILION G, Vu H, Xiong Z, Dang TVT, et al
    Spatial analysis of HPV-associated cervical intraepithelial neoplastic tissues demonstrate distinct immune signatures associated with cervical cancer progression.
    J Pathol. 2025 Dec 9. doi: 10.1002/path.70002.
    PubMed    
    Abstract available

  204. OZDEMIR CY, Marangoz B, Cicekli N, Savas M, et al
    HPV vaccine awareness and vaccination status among women of reproductive age in Turkiye: A cross-sectional study.
    Hum Vaccin Immunother. 2025;21:2586826.
    PubMed    
    Abstract available

  205. NISHIYAMA M, Okada T, Uetsuki T, Jinzai Y, et al
    [Surgical Resection of Metastatic Cardiac Tumors].
    Kyobu Geka. 2025;78:1082-1087.
    PubMed    
    Abstract available

  206. RUSATIRA JC, Uwimana JB, Rutagumba D, Byiringiro S, et al
    Investigating the mental health burden amongst breast and cervical cancer patients in Rwanda using a modified self-reported questionnaire for mental health screening (SRQ-20): A validation study.
    BMC Womens Health. 2025 Dec 8. doi: 10.1186/s12905-025-04207.
    PubMed    


  207. KUENGHAKIT S, Newnham A, Ismail M
    Expectant management of missed miscarriage in a post-trachelectomy patient with permanent cervical cerclage.
    BMJ Case Rep. 2025;18:e270092.
    PubMed    
    Abstract available

  208. GOMES MADEIRA C, Marotta C, Ditter AG, Raviglione MCB, et al
    Participation in cervical cancer screening among migrants and non-migrants in primary healthcare in Lisbon: a register-based study.
    BMJ Glob Health. 2025;10:e019061.
    PubMed    
    Abstract available

  209. WEIL CR, Brower J, Small W Jr, Gaffney DK, et al
    Immunotherapy in the upfront definitive management of locally advanced cervical cancer: An evolving treatment paradigm.
    Pract Radiat Oncol. 2025 Dec 6:S1879-8500(25)00312.
    PubMed    
    Abstract available

  210. LIU H, Zhou J, Xiao Y, Zheng Y, et al
    High-Throughput Targeted Sequencing Identifies an HPV Methylation Panel for Detecting Cervical Lesion Progression.
    J Med Virol. 2025;97:e70739.
    PubMed    
    Abstract available

  211. SCOTT H, Stevenson A, Mair D, Rooney WM, et al
    Viability of Self-Taken Vaginal Swab Samples for RNA-Based Biomarker Analysis in Cervical Disease.
    J Med Virol. 2025;97:e70737.
    PubMed    
    Abstract available

  212. YANG Q, Jiang Y, Liu F, Chang L, et al
    Comparative evaluation of two DNA methylation assays for triage of hrHPV E6/E7 mRNA-positive women.
    Front Public Health. 2025;13:1723553.
    PubMed    
    Abstract available

  213. SUN QQ, Ke FF, Zhou HY, Zhou SJ, et al
    Mindfulness-based stress reduction for sexual psychological recovery after radical cervical cancer surgery: A retrospective study.
    World J Psychiatry. 2025;15:112655.
    PubMed    
    Abstract available

  214. MA J, Xu H, Yang B, Han X, et al
    Construction of a psychological intervention program to support fear of recurrence in patients with cervical cancer.
    World J Psychiatry. 2025;15:112651.
    PubMed    
    Abstract available

  215. XIE ZJ, Zhang H, Ma RY, Su HL, et al
    Influencing factors and predictive model construction of anxiety and depression in patients with cervical cancer.
    World J Psychiatry. 2025;15:111761.
    PubMed    
    Abstract available

  216. MALIAKKAL BABU JS, Subashini P, Dhivyaprabha TT
    Advancing Cervical Cancer Care: A Comprehensive Study of Screening Approach for Tribal Women in Sub-Saharan Africa and Asia.
    Iran J Public Health. 2025;54:2151-2160.
    PubMed    
    Abstract available

  217. HU M, Chen X, Tong X, Hao C, et al
    Case Report: Rapid resolution of malignant acanthosis nigricans following chemotherapy for cervical cancer.
    Front Oncol. 2025;15:1694975.
    PubMed    
    Abstract available

  218. LIU H, Chang X, Hong Y, Yin H, et al
    Efficacy and safety of anlotinib hydrochloride combined with concurrent radiotherapy in the treatment of locally advanced cervical cancer: a single-arm, single-center, exploratory, phase II clinical study.
    Front Oncol. 2025;15:1662160.
    PubMed    
    Abstract available

  219. WANG X, Du L, Xue Y, Su Y, et al
    Design, synthesis and anti-cervical cancer activity of aroylpyrrole-based derivatives as potent histone deacetylase 6 inhibitors.
    RSC Adv. 2025;15:47637-47647.
    PubMed    
    Abstract available

  220. MO L, Liang R, Wang X, Xiao Z, et al
    Effect of enhanced recovery after surgery-based perioperative nursing on postoperative pain and recovery in patients with cervical cancer: A retrospective cohort study.
    Exp Ther Med. 2025;31:30.
    PubMed    
    Abstract available

  221. SINHA R, Portmann-Baracco A, Gorman AR, Stock EC, et al
    Impact of Interruptions in Chemotherapy on Survival for Patients With Metastatic or Recurrent Cervical Cancer.
    Am J Clin Oncol. 2025 Dec 8. doi: 10.1097/COC.0000000000001279.
    PubMed    
    Abstract available

  222. TENG XL, Ran CH, Ding CX, Zhang JJ, et al
    [SMARCA4-deficient tumors of the female reproductive system: a clinicopathological analysis of five cases].
    Zhonghua Bing Li Xue Za Zhi. 2025;54:1338-1340.
    PubMed    


  223. ZHAO J, Luo RK, Zhang LL, Gu WY, et al
    [Atypical forms of microglandular hyperplasia of the cervix: a clinicopathological analysis of 29 cases].
    Zhonghua Bing Li Xue Za Zhi. 2025;54:1311-1316.
    PubMed    
    Abstract available

  224. YU M, Ni M, Xu F, Fang C, et al
    Overexpressed CD24 and CD47 Indicate a Worse Prognosis in Cervical Cancer.
    Cancer Med. 2025;14:e71443.
    PubMed    
    Abstract available

  225. LI B, Fu Y, Wang R, Wang Q, et al
    miR-338-3p targets WAPL to suppress proliferation and invasion in cervical cancer cells: experimental insights.
    World J Surg Oncol. 2025 Dec 7. doi: 10.1186/s12957-025-04125.
    PubMed    
    Abstract available

  226. BERZA N, Stars I, Zodzika J, Kivite-Urtane A, et al
    Understanding hesitancy: barriers to HR-HPV self-sampling among women at high risk for cervical cancer in Latvia.
    BMC Womens Health. 2025 Dec 7. doi: 10.1186/s12905-025-04205.
    PubMed    
    Abstract available

  227. SINGH S, Sahu C, Singh P, Mishra A, et al
    Refining cell classification for cervical cancer detection using an improved high dimensional feature fusion approach.
    Med Eng Phys. 2025;146:104445.
    PubMed    
    Abstract available

  228. GUO L, Zhang Q
    Identification of MFSD3 as a potential prognostic biomarker of cervical cancer.
    Discov Oncol. 2025 Dec 6. doi: 10.1007/s12672-025-04184.
    PubMed    
    Abstract available

  229. ZHAO X, Zhang J, Xia Y, Liu S, et al
    Diagnostic Efficacy of Serum PDCD4 and HSP70 Levels for Lymph Node Metastasis in Early Cervical Cancer.
    J Coll Physicians Surg Pak. 2025;35:1568-1573.
    PubMed    
    Abstract available

  230. CAO D, Jin J, Han J, Yang B, et al
    MDA-TransUNet: A Deep Learning-Based Automatic Segmentation Method for Cervical Cancer Brachytherapy.
    Technol Cancer Res Treat. 2025;24:15330338251397035.
    PubMed    
    Abstract available

  231. BRENNA I, Mjolstad BP, Baasland I, Gilstad H, et al
    Communicating abnormal cervical cancer screening results - a focus group study with general practitioners in Norway.
    Scand J Prim Health Care. 2025 Dec 5:1-13. doi: 10.1080/02813432.2025.2597785.
    PubMed    
    Abstract available

  232. YE H, Zhang Y, Geng L, Li Z, et al
    [Retracted] Cdc42 expression in cervical cancer and its effects on cervical tumor invasion and migration.
    Int J Oncol. 2026;68:20.
    PubMed    
    Abstract available


  233. Correction to "Circular RNA circRNA_101996 Promoted Cervical Cancer Development by Regulating miR-1236-3p/TRIM37 Axis".
    Kaohsiung J Med Sci. 2025 Dec 5:e70151. doi: 10.1002/kjm2.70151.
    PubMed    


  234. SU L, Yao J, Ai X, Xu R, et al
    Short videos platforms as sources of health information about cervical cancer screening: A content and quality analysis.
    Digit Health. 2025;11:20552076251404516.
    PubMed    
    Abstract available

  235. ZHANG L, Ai C, Yu S, Li K, et al
    Successful sequential chemo-immunotherapy and reduced-volume brachytherapy for bulky residual cervical tumor after external beam radiotherapy: two case reports.
    Front Immunol. 2025;16:1687247.
    PubMed    
    Abstract available

  236. SANTOS N, Kim J, Hsu K, Gemson E, et al
    Association Between Age and Race and Cervical Cancer Stage.
    O G Open. 2025;2:e138.
    PubMed    
    Abstract available

  237. MOSQUERA I, Chandran A, Rol ML, Mesmin Olivier AY, et al
    Assessment of barriers to the cervical cancer continuum and existing interventions in 5 African countries.
    BMC Public Health. 2025 Dec 4. doi: 10.1186/s12889-025-25733.
    PubMed    


  238. ZHANG L, Zhang Y, Wang X, Tang C, et al
    Is the domestic bivalent HPV vaccine cost-effective compared with quadrivalent or nine-valent HPV vaccines in the context of cervical cancer screening? A modeling study.
    BMC Public Health. 2025 Dec 4. doi: 10.1186/s12889-025-25797.
    PubMed    
    Abstract available

  239. SARGAZI V, Naseri S, Gholamhosseinian H, Momennezhad M, et al
    Applicator reconstruction in cervical cancer brachytherapy: A systematic review of current methods, challenges, and AI-driven future directions.
    Brachytherapy. 2025 Dec 3:S1538-4721(25)00325.
    PubMed    
    Abstract available

  240. DANG S, Tang X, Li Q, Wu J, et al
    Xiao-Liu Tang (XLT), a traditional Chinese medicine formula that suppresses the progression of cervical cancer by inducing apoptosis and inhibiting cell migration.
    J Ethnopharmacol. 2025;358:120966.
    PubMed    
    Abstract available

  241. QURIESHI MA, Haq I, Malik TZ, Ahmad SZ, et al
    Association Between Male Circumcision and Cervical Cancer Risk: A Systematic Review and Meta-Analysis of Analytical Studies.
    JCO Glob Oncol. 2025;11:e2500126.
    PubMed    
    Abstract available

  242. WANG S, She C, Xu G, Hu X, et al
    A Study on the Improvement of Quality of Survival in Cervical Cancer Patients after Chemoradiotherapy through an Integrated Traditional Chinese and Western Medicine Therapy Based on a Syndrome Differentiation-Driven Dynamic Intervention Strategy.
    Oncology. 2025 Dec 4:1-15. doi: 10.1159/000548661.
    PubMed    
    Abstract available

  243. PEI C, Zeng D, He C, Sun W, et al
    A national survey on HPV vaccination status among 42,800 female physicians and nurses in China, 2021.
    Vaccine. 2025;70:128025.
    PubMed    
    Abstract available

  244. KELLY SA, Changalucha J, Malibwa D, Ewing VL, et al
    Knowledge and acceptability of male HPV vaccination among young people and community stakeholders in northwest Tanzania: social sciences in the Add-Vacc trial.
    Vaccine. 2025;69:128002.
    PubMed    
    Abstract available

  245. DOULOU K, Bacopoulou F, Michos A, Tsolakidis A, et al
    HPV vaccination coverage among children and adolescents in Greece using national prescription data.
    Vaccine. 2025;70:128026.
    PubMed    
    Abstract available

  246. SOUZA APO, Lima LA, Ferreira PAB, Maux JML, et al
    An electrochemical immunosensor for intraepithelial neoplasia in cervicovaginal lavage using a fullerene-TCNQ platform for p16 detection.
    Anal Bioanal Chem. 2025;417:6933-6946.
    PubMed    
    Abstract available

  247. NJOH AA, Bolio A, Venczel L, Libwea JN, et al
    Key players and determinants improving human papillomavirus vaccination coverage in Cameroon: a cross-sectional nationwide health workers survey.
    Vaccine. 2025;69:128006.
    PubMed    
    Abstract available

  248. PETROS H, Destaw A, Getachew S, Ahmed I, et al
    Prevalence and associated factors of persistent precancerous lesions among women treated for cervical lesions in Addis Ababa, Ethiopia.
    Oncologist. 2025;30:oyaf392.
    PubMed    
    Abstract available

  249. ARAGAW FM, Dawson A, Lekkas P, Yeo S, et al
    Cancer screening uptake among refugees in high and middle-income countries: a systematic review.
    Prev Med. 2026;202:108469.
    PubMed    
    Abstract available

  250. GICHOYA JW, Mwavu R, Minja F, Kaonga N, et al
    Leveraging digital technologies to reduce cancer disparities in low-income and middle-income countries.
    Lancet Digit Health. 2025;7:100937.
    PubMed    
    Abstract available

  251. DAI J, Yang R, Cun Y, Zhang X, et al
    Precision design of an HLA-I-targeted multiepitope vaccine against human papillomavirus 16 oncoproteins E6/E7: integrated immunoinformatic and immunogenicity profiling.
    Anticancer Drugs. 2026;37:58-66.
    PubMed    
    Abstract available

  252. LI X, Li H
    Assessing the role of bisphenol A in female reproductive cancers using network toxicology, molecular dynamics, and preliminary experimental validation.
    Food Chem Toxicol. 2026;207:115827.
    PubMed    
    Abstract available

  253. HE Y, Zhao M, Zhang H, Ji M, et al
    Deep learning enhanced label-free cervical screening via stimulated Raman cytology.
    Talanta. 2026;298.
    PubMed    
    Abstract available

  254. CHEN F, Hillemanns P, Ruan H, Chen X, et al
    Photodynamic therapy for high-grade squamous intraepithelial lesions: A randomized controlled trial.
    Med. 2025;6:100851.
    PubMed    
    Abstract available

  255. ERDIREN N, Atik TK, Turan G, Sener AG, et al
    High-risk HPV genotype distribution and prevalence in cervical swabs from Western Turkey.
    Diagn Microbiol Infect Dis. 2026;114:117132.
    PubMed    
    Abstract available

  256. SHENG J, Luan J, Zhao Y, Xing Y, et al
    Clonal origins and divergent evolutionary relationships of synchronous multiple malignant neoplasms in gynecology revealed by next-generation sequencing.
    Cancer Treat Res Commun. 2025;45:101013.
    PubMed    
    Abstract available

  257. ZHANG L, Chen W, Hou Y, Gao P, et al
    Incidence, prevalence, deaths, and DALYs of diseases of the female reproductive system from 1990 to 2021 across 204 countries: data, with critical re-analysis, from the global burden of disease study.
    Int J Surg. 2025;111:9166-9177.
    PubMed    
    Abstract available

  258. HAAS JS, Todd KW, Mclerran D, Tiro JA, et al
    Gaps in care across the cancer screening continuum for cervical, colorectal and lung cancer.
    J Natl Cancer Inst. 2025 Sep 10:djaf248. doi: 10.1093.
    PubMed    
    Abstract available

  259. MARSDEN KA, Wilkinson ZA, Dyhdalo KS, Hoda RS, et al
    Acidic alterations: impact of glacial acetic acid treatment on interpretations of atypical endocervical and atypical glandular cells, not otherwise specified in Pap tests.
    J Am Soc Cytopathol. 2025;14:428-433.
    PubMed    
    Abstract available

  260. MAJUMDER A, Rekhi B, Mittal N, Menon S, et al
    Carcinosarcoma of the cervix: Clinicopathological features of 17 tumors diagnosed at a Tertiary Cancer Referral Centre, India.
    Indian J Pathol Microbiol. 2025;68:744-753.
    PubMed    
    Abstract available

  261. JONES TE, Zeng X, Matsko J, Harinath L, et al
    The clinical significance of atypical glandular cells in Papanicolaou tests: changes in diagnostic patterns over 15 years at a single institution.
    J Am Soc Cytopathol. 2025;14:434-443.
    PubMed    
    Abstract available

  262. KIBAR A, Sahin OE, Sayman HB
    FDG PET/CT Image of Extrarenal Wilms Tumor of Cervix.
    Clin Nucl Med. 2025 May 8. doi: 10.1097/RLU.0000000000005941.
    PubMed    
    Abstract available

  263. TAO L, Zhou D, Luo M, Duan Z, et al
    The relationship between atypical glandular cells and malignancy risk: a retrospective single-center study.
    Eur J Cancer Prev. 2026;35:21-28.
    PubMed    
    Abstract available

  264. AZZI A, Al-Dhelaan R, Al-Fahd A, Almukhalafi O, et al
    Assessment of awareness level among women about cervical smears, human papillomavirus (HPV), and HPV vaccine in Saudi Arabia.
    Sci Rep. 2025;15:44171.
    PubMed    
    Abstract available

  265. WANG H, Liu S, Li P, Zhang YS, et al
    PRDM1-driven SLC30A9 overexpression contributes to the malignant phenotype of cervical cancer cells via promoting mitochondrial hyperfunction.
    Cell Death Dis. 2025;16:895.
    PubMed    
    Abstract available

  266. WANG B, Zhu Y, Ru Z, Zhang Y, et al
    The role of SIGLEC9 in immunosuppression and prognosis in cervical cancer.
    Clinics (Sao Paulo). 2025;81:100849.
    PubMed    
    Abstract available

  267. HALL MT, Hyatt A, Smith MA, Torode J, et al
    Elimination of cervical cancer: the impact of HPV vaccination, primary HPV screening, and expanded access to cancer treatment services.
    Mol Aspects Med. 2025;107:101423.
    PubMed    
    Abstract available

  268. BHATLA N, Shamsunder S, Zutshi V, Singh U, et al
    Resource-Based Good Clinical Practice Recommendations for Colposcopy Standards and Quality Assurance in Colposcopy Practice.
    J Low Genit Tract Dis. 2026;30:88-96.
    PubMed    
    Abstract available

  269. MICHAAN N, Laskov I, Joubran J, Solomon N, et al
    Use of Virtual Reality for Pain Relief During Cervical Conization Under Local Anesthesia: A Randomized Controlled Trial.
    J Low Genit Tract Dis. 2026;30:43-47.
    PubMed    
    Abstract available

  270. DENG S, Liu L, Lin J, Xiong Z, et al
    Construction of a predictive model for radiation proctitis after radical radiotherapy for cervical cancer based on MRI radiomics.
    Abdom Radiol (NY). 2025 Dec 19. doi: 10.1007/s00261-025-05333.
    PubMed    
    Abstract available

  271. LE X, Chen Q, Cao S, Hu G, et al
    Pan-Cdk inhibitor ZK304709 suppresses Cdc20 expression and potentiates the anticancer activity of apcin in HeLa cervical cancer cells.
    Acta Pharm. 2025 Dec 17. doi: 10.2478/acph-2026-0002.
    PubMed    
    Abstract available

  272. KWEHAYO P, Musaba MW, Oguttu F, Olowo S, et al
    Factors associated with utilization of cervical cancer screening services among women at a tertiary hospital in eastern Uganda: A cross sectional study.
    Int J Afr Nurs Sci. 2025;23:100897.
    PubMed    
    Abstract available

  273. BAI G, Chen F, Qiu J, Hua K, et al
    Machine learning-based prediction of clinical outcomes in cervical cancer using routine hematological indices: development and web implementation.
    Front Oncol. 2025;15:1661153.
    PubMed    
    Abstract available

  274. SHRIVASTAVA SR, Bobhate PS, Pratidina KL
    Integrating Cervical Cancer Screening into Rural Healthcare Delivery Systems for Better Patient Outcomes.
    J Midlife Health. 2025;16:492-495.
    PubMed    
    Abstract available

  275. KUMARI S, Agrawal S, Nigam N, Singh N, et al
    Association between NAD (P) H: Quinone Oxidoreductase 1 C609T Gene Polymorphism and Risk Factors in Cases of Cervical Cancer in Indian Women.
    J Midlife Health. 2025;16:425-433.
    PubMed    
    Abstract available

  276. SEKMEN MI, Koca T, Cetmi DA, Bilek Y, et al
    Simultaneous integrated boost in locally advanced cervical cancer patients ineligible for brachytherapy: Dosimetric comparison of VMAT versus helical tomotherapy.
    J Appl Clin Med Phys. 2026;27:e70418.
    PubMed    
    Abstract available

  277. HATHAWAY CL, Hall M, de Bondt D, Broshkevitch CJ, et al
    The impact of HIV on cervical cancer elimination in Kwazulu-Natal: a comparative modeling analysis.
    J Natl Cancer Inst. 2025 Dec 18:djaf364. doi: 10.1093.
    PubMed    
    Abstract available

  278. WANG L, Wang L, Cao Y, Wang Q, et al
    A chemokine-based prognostic model featuring CXCL8, ITGA5, BACE2, CCR7, CERS4, and MEI1 for cervical cancer.
    Eur J Med Res. 2025 Dec 18. doi: 10.1186/s40001-025-03688.
    PubMed    
    Abstract available

  279. RIGGENBACH E, Mose L, Imboden S, Siegenthaler F, et al
    Intensified radiochemotherapy with cisplatin and gemcitabine for cervical cancer in the modern era: a retrospective cohort study.
    J Gynecol Oncol. 2025 Dec 8. doi: 10.3802/jgo.2026.
    PubMed    
    Abstract available

  280. DOLCIAMI M, Criscione M, Bizzarri N, Amerighi A, et al
    Accuracy and clinical impact of MRI in early-stage cervical cancer after cervical conization, a retrospective study.
    Eur Radiol. 2025 Dec 18. doi: 10.1007/s00330-025-12178.
    PubMed    
    Abstract available

  281. GIANELLA C, Salmon-Mulanovich G, Bohorquez-Gutierrez J, Tapia P, et al
    Political determinants of cervical cancer control in Peru.
    BMC Health Serv Res. 2025;25:1605.
    PubMed    
    Abstract available

  282. NAZRUL N, Rahman A, de Fouw M, Campbell C, et al
    Cervical high-risk human papillomavirus infection and its associated risk factors: a community-based cross-sectional study in hard-to-reach areas in Bangladesh.
    BMJ Open. 2025;15:e103915.
    PubMed    
    Abstract available

  283. COSTA MT, Tavares V, Adega F, Medeiros R, et al
    Non-Coding RNAs and Liquid Biopsies: Emerging Biomarkers for Cervical Cancer.
    Crit Rev Oncol Hematol. 2025 Dec 16:105091.
    PubMed    
    Abstract available

  284. ERASO Y, Stefler D, Whitelock V, Clarke E, et al
    Women's initial preferences for self-sampling tests at home for cervical cancer screening in the UK: A mixed-methods analysis of demographic and behavioural factors.
    Public Health. 2025;251:106109.
    PubMed    
    Abstract available

  285. BAJINKA O, Touray M, Barrow A, Ouedraogo SY, et al
    Cancer education and capacity in sub-Saharan Africa-where do we stand?
    Health Educ Res. 2025;40:cyaf062.
    PubMed    
    Abstract available

  286. PRATT R, Bliss Barsness C, Lin J, Adan F, et al
    Experience with Cervical Cancer Screening and Views on HPV Self-Sampling Among Somali American Women.
    J Gen Intern Med. 2025 Dec 18. doi: 10.1007/s11606-025-10080.
    PubMed    
    Abstract available

  287. ASHING K, Blackman E, Song G, Gibbs D, et al
    Exploring quality of life impact on cancer screening in Black subgroups.
    Ann Behav Med. 2025;59:kaaf078.
    PubMed    
    Abstract available

  288. MANZANO-CHAYA JS, Mendoza-Herrera T, Garcia-Ayala E
    [Uso de la inteligencia artificial en el diagnostico de alteraciones de la citologia cervicouterina: estudio observacional en poblacion universitaria].
    Biomedica. 2025;45.
    PubMed    
    Abstract available

  289. SUN L, Lang J, Wu X, Shi D, et al
    Complete remission of recurrent human papillomavirus-associated cervical cancer managed with camrelizumab and nanoparticle albumin-bound paclitaxel as second-line treatment: a case report.
    Front Immunol. 2025;16:1679950.
    PubMed    
    Abstract available

  290. WANG F, Liu Y, Wang L, Bai Y, et al
    Ginkgetin reverses cisplatin resistance in cervical cancer by regulating the Nrf2/HO-1 signaling pathway to induce ferroptosis.
    Sci Rep. 2025 Dec 17. doi: 10.1038/s41598-025-33111.
    PubMed    
    Abstract available

  291. MA Y, Shi S
    The impact of sequential chemoradiotherapy versus concurrent chemoradiotherapy on prognosis in adjuvant treatment after radical hysterectomy for cervical cancer.
    World J Surg Oncol. 2025 Dec 17. doi: 10.1186/s12957-025-04149.
    PubMed    


  292. OZMEN F, Ozata B, Erol B
    Evaluation of systemic inflammation- and nutrition-based indices in the prediction of HPV persistence.
    BMC Womens Health. 2025;25:598.
    PubMed    
    Abstract available

  293. WEI H, Wang X, Wang Q, Lin B, et al
    Tie1 derived from cervical cancer promotes the invasion and metastasis by Ang1 mediating Tie2/PI3K/Akt signaling axis and angiogenesis.
    Sci Rep. 2025;15:43979.
    PubMed    
    Abstract available

  294. TESFAYE H, Mezmur H, Ahmed N, Tesfaye G, et al
    Human papillomavirus vaccine uptake and associated factors among in-school adolescent girls in Harari regional state, Eastern Ethiopia: a cross-sectional study.
    BMJ Open. 2025;15:e101727.
    PubMed    
    Abstract available

  295. DINAMANI SINGH S, Nagamani S
    Deciphering virus host interaction analysis to unravel core virus network signatures and computational drug repurposing for cervical cancer.
    Comput Biol Med. 2025;200:111395.
    PubMed    
    Abstract available

  296. HEGDE V, Bhat RM, Muddapur GV, Shettar AK, et al
    Discovery of Novel Oxadiazole-Triazole Hybrids as Lung and Cervical Cancer Agents: Synthesis, Docking, Biological Evaluation, and SAR Studies.
    Chem Biol Drug Des. 2025;106:e70225.
    PubMed    
    Abstract available

  297. TSHIRURUVHELA FM, Makhubu MJ, Marincowitz GJO, Marincowitz C, et al
    Factors contributing to delayed diagnosis of cervical cancer in human immunodeficiency virus-positive women.
    S Afr Fam Pract (2004). 2025;67:e1-e6.
    PubMed    
    Abstract available

  298. BONNEY EY, Gyekye EF, Klutse J, Attoh DA, et al
    Barriers and facilitators of integrating cervical cancer screening into routine HIV care and acceptability of self-sampling for HPV DNA testing among people with HIV: an exploratory study in southern Ghana.
    Front Public Health. 2025;13:1679325.
    PubMed    
    Abstract available

  299. ABDUS-SALAM AA, Yusuf SA, Ehiedu ECG, Adeleke OK, et al
    HUMAN IMMUNODEFICIENCY VIRUS IN CERVICAL CANCER PATIENTS TREATED WITH RADIOTHERAPY IN IBADAN, NIGERIA; A REVISIT.
    Ann Ib Postgrad Med. 2025;23:83-87.
    PubMed    
    Abstract available

  300. SALAZAR C, Walter E, Yang TY, Goel MS, et al
    Health-Related Social Needs and Cervical Cancer Screening in Alliance Chicago Community Health Centers.
    AJPM Focus. 2025;5:100439.
    PubMed    
    Abstract available

  301. KHARI M, Jain N, Kaul S, Pandey M, et al
    siRNA and mRNA-Based Preventive and Therapeutic Strategies for HPV-Induced Cervical Cancer.
    Adv Pharm Bull. 2025;15:552-573.
    PubMed    
    Abstract available

  302. KARAMI H, Soleimani-Jelodar R, Khezeli Z, Shoja Z, et al
    Exploring the association between the lineages of human papillomavirus type 16 and viral physical status in the development of cervical cancer in Iran.
    Sci Rep. 2025;15:43922.
    PubMed    
    Abstract available

  303. GARCIA-BALAGUERA C, Ruiz Rodriguez SP
    [Delays in the diagnosis and treatment of cervical cancer in the department of Meta, 2017-2023: a cross-sectional study].
    Rev Colomb Obstet Ginecol. 2025;76:4277.
    PubMed    
    Abstract available

  304. SINGH K, Grover A, Dhanasekaran K
    Cervical cancer burden in India: A descriptive epidemiological study and policy insights.
    Glob Epidemiol. 2025;10:100233.
    PubMed    
    Abstract available

  305. MAYOUDOM TAGNE PJ, Ketchaji A, Kegha Ngodem VC, Moyo Tachoum JR, et al
    Cervical cancer screening and associated factors in women living with HIV followed at Bonassama District Hospital, Cameroon.
    J Public Health Res. 2025;14:22799036251401946.
    PubMed    
    Abstract available

  306. BAI Y, Wu S, Zhang L
    Impact of Intraoperative Ultrasound-Guided Loop Electrosurgical Excision Procedure With Individualized Marking on Perioperative Stress Responses, Immune Parameters, and Clinical Outcomes: A Comparative Study With Conventional Surgery.
    Ann Ital Chir. 2025;96:1633-1640.
    PubMed    
    Abstract available

  307. SAKAI A, Yahata H, Sugiura T, Nakahara K, et al
    Obstetric Outcome After Trachelectomy for Cervical Cancer Without Uterine Artery Preservation.
    J Obstet Gynaecol Res. 2025;51:e70170.
    PubMed    
    Abstract available

  308. YE Y, Wang Y, Gong D, Zhao Y, et al
    Identification and experimental validation of copper metabolism-related genes in cervical cancer.
    Medicine (Baltimore). 2025;104:e46387.
    PubMed    
    Abstract available

  309. WANG J, Song G, Hussain L, Xing L, et al
    Deciphering the pharmacological mechanisms of salidroside in cervical cancer by combining network pharmacology, molecular docking, and in vitro studies.
    Saudi Pharm J. 2025;33:49.
    PubMed    
    Abstract available

  310. ABDULAI AM, Sisala IM, Issah I, Kyiu C, et al
    Knowledge, attitudes, and barriers to cervical cancer screening utilization among female healthcare professionals in the Tamale Metropolis.
    Womens Health (Lond). 2025;21:17455057251401319.
    PubMed    
    Abstract available

  311. MA J, Zhu W, Zhao R, Shi Q, et al
    CD155-based chimeric antigen receptor T cells: a promising immunotherapy for cervical and breast cancer.
    Front Immunol. 2025;16:1631812.
    PubMed    
    Abstract available

  312. JIANG F, Zhou P
    Prognostic significance of systemic immune inflammation index and systemic inflammation response index for cervical cancer: A systematic review and meta-analysis.
    Pak J Med Sci. 2025;41:3306-3315.
    PubMed    
    Abstract available

  313. MASUM MHU, Parvin R, Heema HP, Akter A, et al
    Exploitation of Biocomputational Approaches for siRNA-Mediated Gene Silencing of HPV: A Novel Therapeutic Strategy for Cervical Cancer.
    Cancer Rep (Hoboken). 2025;8:e70434.
    PubMed    
    Abstract available

  314. XUAN Y, Liu M, Gao L
    Letter to "Fertility-Sparing Trachelectomy With Sentinel Node Mapping in Early-Stage Cervical Cancer: Oncological Safety and Obstetric Outcomes From a Single-Institution Study".
    J Obstet Gynaecol Res. 2025;51:e70165.
    PubMed    


  315. REMKES A, Zafinimampera A, Totofotsy O, Ratiaharison FE, et al
    Human papillomavirus awareness and vaccination willingness among adults in Madagascar: a cross-sectional study.
    BMC Womens Health. 2025;25:596.
    PubMed    
    Abstract available

  316. HUANG S, Gentil LG, Schmidt C, Cullum R, et al
    Clinical Performance of HPV DNA and HPV RNA Assays for the Detection of High-Grade Cervical Lesions.
    J Low Genit Tract Dis. 2026;30:25-30.
    PubMed    
    Abstract available

  317. CHODICK G, Adler L, Liran O, Mizrahi-Reuveni M, et al
    Follow-up of Women Testing Positive for Human Papillomavirus Non-16/18 With Normal Cytology in a Screening Context.
    J Low Genit Tract Dis. 2026;30:22-24.
    PubMed    
    Abstract available

  318. SINAN S, Kooistra RM, Rajaraman K, Islam Z, et al
    One-Pot Isothermal Linear Amplification and Cas12a-Based Nucleic Acid Detection.
    ACS Synth Biol. 2025;14:4714-4722.
    PubMed    
    Abstract available

  319. DU H, Jiang X, Liu Y, Hou J, et al
    One-year restoration of vaginal health: synergistic dynamics of microbiome and metabolome following the elimination of high-grade cervical intraepithelial neoplasia.
    mSystems. 2025;10:e0119025.
    PubMed    
    Abstract available

  320. LIU L, Zhao X
    Multilevel Transcriptomic Association Analysis Reveals Key Genes and Potential Mechanisms in Endometrial, Ovarian, and Cervical Cancers.
    Reprod Sci. 2025;32:3887-3898.
    PubMed    
    Abstract available

  321. CLARK C, Aquilina A, Perkins RB, Papagiannakis E, et al
    Automating the Detection of Acetowhite Lesions by Classifying the Temporal Behavior of Cervical Regions.
    J Low Genit Tract Dis. 2026;30:31-38.
    PubMed    
    Abstract available

  322. FINE JR, Bartel CM, Conde ST, Abdullah BA, et al
    Effects of Adherence to Colposcopy Guidelines on the Detection of Cervical Intraepithelial Neoplasia.
    J Low Genit Tract Dis. 2026;30:17-21.
    PubMed    
    Abstract available

  323. SUN Y, Smith C, Murray J, Zhu J, et al
    Comparative Analysis Reveals Recurrent Molecular Alterations in Low-Risk Human Papillomavirus 6 and Human Papillomavirus 11-Associated Squamous Cell Carcinoma of the Uterine Cervix and Vulva.
    Mod Pathol. 2025;38:100909.
    PubMed    
    Abstract available

  324. GAO Y, Wen Q, Qiao S, Deng L, et al
    A Field-Deployable RotEx-LAMP-LFA Platform for Molecular Triage of HPV-Driven Oncogenesis.
    Adv Sci (Weinh). 2025;12:e09468.
    PubMed    
    Abstract available

  325. CASTANHEIRA CP, Lorenzi NPC, Chiarot FD, Cassenote AJF, et al
    Self-sampling for HPV genotyping: a study of vaginal and urine collection in Brazilian women with high-grade lesions.
    Clinics (Sao Paulo). 2025;80:100780.
    PubMed    
    Abstract available

  326. MAHONEY KM, Bravo L, McAllister A, Bogar K, et al
    Reproductive Health Services in Abortion-Providing Clinics: A Scoping Review of Provision and Policy Contexts.
    Womens Health Issues. 2025;35:424-441.
    PubMed    
    Abstract available

  327. AWADALLA M, Al Rawi HZ, Alahmadi RM, Khojah OT, et al
    Transcriptomic profile of the immune genes, oncogenes, and tumor suppressor genes in HPV associated Cervical Intraepithelial Neoplasia 3 (CIN 3) and Cervical Squamous Cell Carcinoma (CSCC): Comparable expressions indicative of invasive potential.
    Tumour Virus Res. 2025;20:200327.
    PubMed    
    Abstract available

  328. XIE Q, Li J, Li J, Liu C, et al
    Spatial Evaluation and Prognostic Significance of V-Domain Immunoglobulin Suppressor of T-Cell Activation (VISTA) in Human Resectable Cervical Carcinoma: Implications for Immune Activation and Suppression.
    Mod Pathol. 2025;38:100851.
    PubMed    
    Abstract available

  329. SONG Y, Gui C, Xian Q, Lv N, et al
    Previously undescribed effects and mechanisms of STAT3 in HPV-induced DNA re-replication in response to DNA damage.
    FEBS J. 2025;292:6592-6607.
    PubMed    
    Abstract available

  330. PARIDA P, Mukherjee N, Singh A, Lewis S, et al
    Precise identification of viral-host integration events in HPV-positive cervical cancers by targeted long-read sequencing.
    Tumour Virus Res. 2025;20:200325.
    PubMed    
    Abstract available

  331. KECZKOWSKA E, Zeber-Lubecka N, Szlendak-Sauer K, Nekanda-Trepka M, et al
    Colposcopy in pregnancy.
    Ginekol Pol. 2025;96:969-973.
    PubMed    
    Abstract available

  332. STRIKWERDA MA, Weerstand SA, Burchell GL, Tromp JM, et al
    The immunological heterogeneity of squamous cell carcinoma and adenocarcinoma of the uterine cervix: a systematic review.
    Tumour Virus Res. 2025;20:200323.
    PubMed    
    Abstract available

  333. GRIFFITHS G, Tomalty D, Adams MA, Giovannetti O, et al
    Assessing knowledge translation following a pre-cancer diagnosis: a multinational evaluation of online resources targeting patients with cervical dysplasia.
    J Commun Healthc. 2025;18:289-298.
    PubMed    
    Abstract available

  334. KOLONGOLO SS, Omondi T, Kutolo E, Guyah B, et al
    Cytomorphological Characteristics of Cervical Scrape from Controlled and Uncontrolled Diabetes Mellitus Patients Attending Tertiary Healthcare, Kenya.
    Acta Cytol. 2025;69:567-575.
    PubMed    
    Abstract available

  335. DELLI CARPINI G, Mammadov Z, Leeson S, Hammer A, et al
    The effect of healthcare disruptions during the COVID-19 pandemic on colposcopy services and practice: A systematic review and meta-analysis.
    Acta Obstet Gynecol Scand. 2025;104:2215-2225.
    PubMed    
    Abstract available

  336. WAN T, Deng T, Peng X, Cai G, et al
    Comprehensive Multi-Omic Characterization of Perineural Invasion in Cervical Cancer Reveals Diagnostic Markers, Molecular Drivers, and Therapeutic Strategies.
    Cancer Res. 2025 Dec 11. doi: 10.1158/0008-5472.CAN-25-0149.
    PubMed    
    Abstract available

  337. CHONG Y, Bychkov A
    Commercially Available Artificial Intelligence Solutions for Gynaecologic Cytology Screening and Their Integration Into Clinical Workflow.
    Cytopathology. 2026;37:24-44.
    PubMed    
    Abstract available

  338. TRESSERRA F, Dinares C, Luque O, Serra M, et al
    Intercenter Study of Interobserver Variability With Optical and Digital Imaging in Cervicovaginal Cytology. Simulation of a Quality Control Program.
    Cytopathology. 2026;37:45-52.
    PubMed    
    Abstract available

  339. MATSUO K, Lee MW, Friedman EL, Erfani H, et al
    Survival assessment of sentinel lymph node biopsy alone without lymphadenectomy for early cervical cancer in real-world data.
    Gynecol Oncol. 2025;204:174-183.
    PubMed    
    Abstract available

  340. HOLTZMAN S, Myers E, Havrilesky LJ, Yamada D, et al
    Gynecologic oncology fellowship trends: Supply outpacing demand, geographical maldistribution.
    Gynecol Oncol. 2025;202:162-166.
    PubMed    
    Abstract available

  341. DRAYER SM, Ogata JD, Cronin S, Tumas J, et al
    Silva pattern-guided proteomics reveals coordinated tumor-stroma remodeling in cervical adenocarcinoma.
    Gynecol Oncol. 2025;202:66-76.
    PubMed    
    Abstract available

  342. MILMAN T, Hoang L, Hamm J, Chai J, et al
    Real-world utility of Silva pattern in predicting outcomes in cervical adenocarcinoma from a population-based series.
    Gynecol Oncol. 2025;202:53-58.
    PubMed    
    Abstract available

  343. VAN DEN BORST E, Vanden Broeck D, De Sutter P, Donders G, et al
    EUROArray HPV test accuracy for cervical precancer in self- vs. clinician-collected samples using the VALHUDES protocol.
    Gynecol Oncol. 2025;202:14-23.
    PubMed    
    Abstract available

  344. FRAYLE H, Gori S, Pagan A, Solda M, et al
    Predictive biomarkers for regression in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2: A prospective multicenter study in Italy.
    Int J Cancer. 2026;158:587-596.
    PubMed    
    Abstract available

  345. PENG H, Li J, Zhou Q, Zhou H, et al
    Enhanced diagnostic accuracy of high-grade cervical intraepithelial neoplasia in postmenopausal women through PAX1/JAM3 methylation analysis.
    Int J Cancer. 2025 Nov 14. doi: 10.1002/ijc.70245.
    PubMed    
    Abstract available

  346. TOTA JE, Shing JZ, Roberts JN, Anderson EM, et al
    Epidemiological approaches to evaluate clinical unmasking of HPV-associated cervical lesions in the HPV vaccination era.
    Int J Cancer. 2025 Sep 15. doi: 10.1002/ijc.70119.
    PubMed    
    Abstract available

  347. VAHTERISTO M, Heinavaara S, Dillner J, Kalliala I, et al
    Long-term human papillomavirus genotype-specific risk of cervical high-grade intraepithelial lesion and cancer-By age group and triage cytology.
    Int J Cancer. 2026;158:931-941.
    PubMed    
    Abstract available

  348. MANISHA M, Singh P, Yadav G, Gothwal M, et al
    Genotype-specific Human Papillomavirus patterns and their implications across the cervical cancer spectrum: A cross-sectional study from Western India.
    Int J Gynaecol Obstet. 2025 Dec 12. doi: 10.1002/ijgo.70730.
    PubMed    
    Abstract available

  349. BAI F, Wu G, Qu X, Shen J, et al
    Optimal adjuvant radiotherapy strategy for cervical cancer: a multi-center database cohort study.
    Int J Gynecol Cancer. 2025;36:102791.
    PubMed    
    Abstract available

  350. SIGNORELLI M, Secchi M
    Correspondence on "Clinical outcomes of external radiotherapy boost versus no boost to radiologically positive lymph nodes in FIGO stage IIIC cervical cancer" by Karthik S Rishi et al.
    Int J Gynecol Cancer. 2025 Nov 4:102777. doi: 10.1016/j.ijgc.2025.102777.
    PubMed    


  351. PAN TL, Friko I, Mwinbe-Ere Der V, Gultekin M, et al
    Building cervical cancer screening capacity in low-resource settings: lessons from Techiman, Ghana.
    Int J Gynecol Cancer. 2025 Nov 28:102808. doi: 10.1016/j.ijgc.2025.102808.
    PubMed    


  352. CONZUELO RODRIGUEZ G, Cremer ML, Soler M, Alfaro K, et al
    Long-term impact of cervical ablation in visual assessment of the squamocolumnar junction: implications for subsequent screening and follow-up.
    Int J Gynecol Cancer. 2025;35:102717.
    PubMed    
    Abstract available

  353. ZHOU J, Cai J, Li X, Liu C, et al
    Pelvic radiotherapy combined with immunotherapy and chemotherapy for stage IVB cervical cancer: a retrospective study.
    Int J Gynecol Cancer. 2025;36:102800.
    PubMed    
    Abstract available

  354. MAYADEV JS, Albuquerque KV, Price JG, Marcrom S, et al
    ARTIA-Cervix: a prospective trial of adaptive radiation therapy for cervical cancer.
    Int J Gynecol Cancer. 2025 Nov 21:102823. doi: 10.1016/j.ijgc.2025.102823.
    PubMed    
    Abstract available

  355. TSEGAYE AT, Clarke MA, Long B, Chappell NP, et al
    Performance of the Alinity m HR HPV assay on self-collected vaginal samples compared to clinician-collected cervical samples.
    J Clin Virol. 2025;181:105883.
    PubMed    
    Abstract available

  356. MARTINELLI M, Hassan SS, Yilmaz E, Lagheden C, et al
    Assessing sample adequacy and clinical performance of self-collected and clinician-collected HPV specimens using internal control Ct values.
    J Clin Virol. 2025;181:105869.
    PubMed    
    Abstract available

  357. QIN J, Martinez G, Holt HK, Gopalani SV, et al
    Preferences Among U.S. Women for Cervical Cancer Screening with Self-Collected Specimens for Human Papillomavirus Testing.
    Obstet Gynecol. 2025 Dec 11. doi: 10.1097/AOG.0000000000006147.
    PubMed    
    Abstract available

  358. JOURA E, Kjaer SK, Bautista O, Luxembourg A, et al
    Effect of Prior 9-Valent Human Papillomavirus Vaccination on Subsequent Lower Genital Tract Dysplasia After Cervical Excisional Surgery.
    Obstet Gynecol. 2026;147:73-82.
    PubMed    
    Abstract available

  359. COVELLI VELEZ I, Youssef A, Li S, Gockley A, et al
    Decline in Rate of Radical Hysterectomies Performed by Gynecologic Oncologists in the United States.
    Obstet Gynecol. 2025 Sep 11. doi: 10.1097/AOG.0000000000006068.
    PubMed    
    Abstract available

  360. LEUNG RC, Liu SS, Chan KY, Tam KF, et al
    [Expression of Concern] Promoter methylation of death?associated protein kinase and its role in irradiation response in cervical cancer.
    Oncol Rep. 2026;55:23.
    PubMed    
    Abstract available

  361. ZIMMERMANN L, Knausl B, Knoth J, Sturdza A, et al
    Diffusion weighted imaging for gross tumor volume delineation in primary radiochemotherapy and image guided adaptive brachytherapy for cervical cancer.
    Radiother Oncol. 2025;214:111306.
    PubMed    
    Abstract available

  362. GULSTENE S, Liu ZA, Milosevic M, Croke J, et al
    Pain control and opioid use as a function of workflow in MRI-guided interstitial cervix brachytherapy.
    Radiother Oncol. 2026;214:111239.
    PubMed    
    Abstract available

  363. XU B, Liu J, Fang M, Zhu H, et al
    Multicenter deep learning-based automatic delineation of CTV and PTV in uterine malignancy CT imaging.
    Radiother Oncol. 2026;214:111212.
    PubMed    
    Abstract available

  364. PAN J, Wei W, Dai B, Wang Y, et al
    Restricted spectrum imaging and diffusion kurtosis imaging for assessing lymph node metastasis in cervical cancer: a histogram analysis-based study.
    BMC Cancer. 2025;25:1817.
    PubMed    
    Abstract available

  365. SU R, Yang D, Chen S, Ding X, et al
    Impact of laparoscopic surgical proficiency on survival outcomes in laparoscopic radical hysterectomy for cervical cancer: a multi-center cohort study.
    BMC Cancer. 2025 Nov 24. doi: 10.1186/s12885-025-15220.
    PubMed    
    Abstract available

  366. ZHAI X, Kong T, Yang X, Yu J, et al
    Clinical performance of triage strategies for HPV-positive women in cervical cancer screening in rural Yunnan China.
    BMC Cancer. 2025 Dec 3. doi: 10.1186/s12885-025-15375.
    PubMed    
    Abstract available

  367. XU L, Guo R, Tang F, Sun X, et al
    Dosimetric analysis of plans using x-ray and gamma-ray combination strategy for advanced cervical cancer patients with pelvic lymph node metastasis.
    BMC Cancer. 2025;25:1836.
    PubMed    
    Abstract available

  368. TESFAW A, Addissie A, Kantelhardt EJ, Getachew S, et al
    Survival status and predictors of mortality among patients with cervical cancer in two oncology units in Northwest Ethiopia: a retrospective follow-up study.
    BMC Cancer. 2025 Dec 17. doi: 10.1186/s12885-025-15444.
    PubMed    


  369. HAN T, Deng S
    Prevalence and genotype distribution of Human Papillomavirus (HPV) among 14,110 women in Anqing urban area: A population-based cross-sectional survey.
    PLoS One. 2025;20:e0336959.
    PubMed    
    Abstract available

  370. MENGISTIE BA, Aragaw GM, Anteneh TA, Wondie KY, et al
    Prevalence and determinants of precancerous cervical lesions among women screened for cervical cancer in Africa: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0338484.
    PubMed    
    Abstract available

  371. NESSA A, Ferdouse J, Khatoon F, Sonia AA, et al
    High-risk human papillomavirus genotypes among women of hill districts in Bangladesh.
    PLoS One. 2025;20:e0338092.
    PubMed    
    Abstract available

  372. YAN Z, Guo C, Liu Y, Li J, et al
    From cervix to multisite: Detection of lower genital tract lesions in a 10-year cross-sectional colposcopy clinic study.
    PLoS One. 2025;20:e0338489.
    PubMed    
    Abstract available

  373. HOQUE R, Cirovic S, Hughes MP, Labeed FH, et al
    Electrophysiological fingerprints of healthy cervical epithelial and HeLa cells: Membrane potential, zeta potential and passive electrical properties.
    PLoS One. 2025;20:e0337538.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;